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Summary  
The murine epicardium is a monolayered epithelium that covers the outer surface of the 
heart. It protects the underlying myocardium and enables the frictionless movement of the 
beating heart within the pericardial cavity. During embryonic development the epicardium 
adding cells for the formation of the coronary vessels and the fibrous heart skeleton. 
Furthermore, the epicardium is a source of trophic signals for the development and 
maturation of the myocardium. The epicardium is derived from an extracardiac precursor cell 
population that is positioned at the venous pole of the linear heart tube of the early embryo. 
Cells of this proepicardium attach to the myocardial surface and form a contiguous epithelial 
lining within a short period of time. Single cells of this epicardium undergo an epithelial-
mesenchymal transition (EMT), invade into the myocardium and differentiate terminally. In 
chick, cell lineage tracing experiments identified smooth muscle cells, perivascular and 
interstitial fibroblast as epicardium-derived cells (EPDCs) as well. In some reports an 
additional coronary endothelial cell fate of EPDCs has been indicated. Two independent 
genetic (cre/loxP-mediated) lineage tracing studies in mouse confirmed that the epicardium 
is a significant source of coronary smooth muscle cells and cardiac fibroblasts as well. A 
contribution of EPDCs to the cardiomyocyte lineage was reported in the mouse, but not in 
other vertebrates. 
To unambiguously identify the fate of epicardial cells, an alternative genetic lineage tracing 
approach was to be performed using a cre knock-in allele of the T-box gene 18 (Tbx18). 
Specific recombination in the right ventricular epicardium allowed to evaluate the final fates 
of EPDCs. Smooth muscle cells, perivascular and interstitial fibroblasts were confirmed as 
epicardium-derived. Re-evaluation of a cre knock-in allele of the Wilms Tumor 1 gene (Wt1), 
which was previously used to confirm epicardial origin of cardiomyocytes, showed ectopic 
recombination within the heart. Thus, this mouse line cannot be used for epicardium-specific 
lineage tracing analysis and conditional knock-outs.  
Furthermore, signaling pathways implicated in the differentiation and the mobilization of 
EPDCs was analyzed or re-evaluated. Conditional alleles of central mediators of these 
signalling pathways were analyzed using the Tbx18cre line. 
With this approach the requirement of the Notch signalling pathway for the differentiation of 
perivascular smooth muscle cells and the necessity of Pdgfrα signalling for EMT and 
fibroblast differentiation was shown. However, the epicardium-specific loss of Ctnnb1, 
Fgfr1/2, Shh and the Hh receptor Smoothened did not affect the mobilization and 
differentiation of EPDCs. In fact, genetic gain-of-function experiments showed that the 
activation of the canonical Wnt and Hh pathways are deleterious for normal epicardial 
development. 
Summary 
 
6 
 
In an independent project, the importance of Upk3b for the efficient sealing of luminal spaces 
was adressed in the mesothelium and urothelium. An Upk3b knock-out mouse was 
generated by homologous recombination in embryonic stem cells and subsequent injection 
into blastocysts. Neither cellular nor molecular changes where observed in the urothelia and 
mesothelia of these mutants. Thus, the loss of Upk3b did not reveal a specific function during 
embryogenesis and in homeostasis. 
 
Keywords: murine heart development, lineage tracing, Wt1, Tbx18, epicardium, Ctnnb1, 
Pdgfrα, Shh, Fgfr 
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Zusammenfassung  
Das Epikard ist ein einschichtiges Epithel, das dem Herzen von Wirbeltieren aufliegt. Es 
schützt das Myokard und ermöglicht die reibungsarme Bewegung des Herzens innerhalb des 
Herzbeutels (Perikard). Während der Embryonalentwicklung leistet das Epikard einen 
zellulären Beitrag zur Bildung des Koronargefäßsystems und des fibrösen Herzskeletts. 
Weiterhin sezerniert das Epikard trophische Faktoren, die für die Entwicklung und Reifung 
des unterliegenden Myokards essentiell sind. Das Epikard leitet sich aus einer extrakardialen 
Vorläuferzellpopulation ab, die mit Beginn der Schlaufenbildung des ursprünglich linearen 
Herzschlauches des frühen Embryos auf dem Septum transversum zu finden ist. Einzelne 
Zellen dieses so genannten Proepikards verlassen daraufhin den Zellverband, adhärieren 
am Myokard und bilden das einschichtige Epikard. Durch einen epithelial-mesenchymalen 
Übergang (EMT) werden einzelne Zellen des Epikards mobilisiert und wandern in den 
subepikardialen Raum und das Myokard ein. Zellschicksalsanalysen im Hühnchen 
identifizierten glatte Muskelzellen, perivaskuläre und interstitielle Bindegewebszellen des 
Herzens als Differenzierungsprodukte epikardial abgeleiteter Zellen (epicardium-derived cells 
- EPDCs). Zwei unabhängige, genetisch vermittelte (cre/loxP) Zellschicksalsanalysen, unter 
Verwendung der regulatorischen Sequenzen von Tbx18 oder Wt1, bestätigten den 
epikardialen Ursprung kardiale Bindegewebszellen und glatter Muskelzellen in der Maus. 
Zusätzlich wurde die Differenzierung von EPDCs in Kardiomyozyten in der Maus 
beschrieben, wenngleich dies nicht in anderen Wirbeltieren bestätigt werden konnte.  
Für die Beurteilung des endgültigen Schicksals epikardialer Zellen wurde eine alternative 
genetische Zellschicksalsanalyse mittels eines cre basierten Ansatzes durchgeführt. Hierbei 
wurde die regulatorische Sequenz des T-box genes 18 (Tbx18) für die zellspezifische 
Expression der Cre-Rekombinase verwandt. Die spezifische Rekombination im Epikard des 
rechten Ventrikels erlaubte eine Zellschicksalsanalyse und es konnte bestätigt werden, dass 
glatte Muskelzellen, perivaskuläre und interstitielle Bindegewebszellen des Herzens 
epikardialen Ursprungs sind. In einer weiteren Studie konnte ich zeigen, dass die, in früheren 
Arbeiten zur Bestätigung des Kardiomyozytenschicksals epikardial abgeleiteter Zellen 
verwendete Wt1cre Linie aufgrund ektopischer Rekombination innerhalb des Herzens nicht 
geeignet ist das Schicksal epikardialer Zellen zu verfolgen oder zu manipulieren. Im 
Weiteren wurden Signalwege für die Differenzierung und Mobilisierung epikardialer Zellen in 
der Embryonalentwicklung untersucht beziehungsweise verifiziert. Hierzu wurden 
konditionelle Allele essentieller Komponenten einzelner Signalwege unter Verwendung der 
Tbx18cre Mauslinie untersucht. Diese Untersuchen zeigten, dass der Notch-Signalweg für die 
Differenzierung von perivaskulären glatten Muskelzellen und der Pdgfrα Signalweg für die 
EMT und Differenzierung von Bindegewebszellen notwendig sind. Im Gegensatz dazu 
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konnte bei der Analyse der Epikard-spezifischen Deletion von Ctnnb1, Fgfr1/2, Shh und des 
Hh Rezeports Smo keine Mobilisierungs- und Differenzierungsdefekte der EPDCs 
nachgewiesen werden. Vielmehr ergaben weitere Untersuchungen, dass die Aktivierung 
sowohl des kanonischen Wnt als auch des Hh Signalwegs schädlich für die epikardiale 
Entwicklung sind.  
In einem unabhängigen Projekt sollte der Beitrag von Upk3b zur Barrierefunktion des 
Mesothels sowie des Urothels untersucht werden. Mittels homologer Rekombination in 
embryonalen Stammzellen der Maus und anschließender Bastozysteninjektion wurden 
Upk3b-Verlustmutanten generiert. Deren Analyse ergab jedoch keine zellulären und 
molekularen Veränderungen des Urothels und des Mesothels. Upk3b besitzt somit keine 
einzigartige Funktion in der Embryonalentwicklung und Homöostase von Urothelien und 
Mesothelien. 
 
Schlagworte: murine Herzentwicklung, Zellschicksalsanalyse, Wt1, Tbx18, Epikard, Ctnnb1, 
Pdgfrα, Shh, Fgfr 
Table of Contents 
   9 
 
Table of Contents 
 Page 
Summary 5
Zusammenfassung 7
Table of Contents 9
Introduction 11
Aim of the Thesis 19
Part 1   “Tbx18 and the fate of epicardial progenitors” 21
Part 2   “Notch signaling regulates smooth muscle differentiation  
  of epicardium-derived cells” 
  Running title: Notch signaling in EPDCs  25
Part 3     “Wt1 and epicardial fate mapping” 51
Part 4     “Epicardial function of canonical Wnt-, Hh-, Fgfr1/2-  
   and Pdgfrα-signaling” 
  Running title: Epicardial signaling pathways 67
Part 5    “Upk3b is dispensable for urothelial and mesothelial  
   development and integrity” 
  Running title: Upk3b in urothelia and mesothelia 105
Concluding remarks 123
References 125
Acknowledgements 131
Curriculum vitae 132
List of publications 133
Declaration 134

Introduction 
   11 
Introduction 
The heart is a highly efficient muscle, pumping blood through the whole body all life long. 
Four chambers are separated by septa and valves to allow a unidirectional blood flow. The 
right ventricle receives the venous blood from the body and pumps it to the lungs, where it is 
oxygenated. The blood returns to the left atrium, which empties into the left ventricle and 
pumps the blood through the aorta into the arterial circuit of the body. The heart is the first 
organ to become functional in the developing embryo, as it is essential for the embryonic 
oxygen and nutrition supply. The developmental process to form a highly complex organ, 
whilst keeping up the constant blood circulation, is a tightly regulated process. Orchestration 
of important transcription factors and control of critical signaling pathways are vital for normal 
heart formation. Inherited heart malformations, i.e. alterations in developmental programs, 
affecting approximately one in hundred live births are and most often treated by surgical 
interventions to prevent postnatal death. Additionally, acquired heart diseases, i.e. 
myocardial infarction, are one of the main causes of death in industrialized nations.1 The 
irreversible loss of cardiomyocytes and coronary vasculature in addition to the formation of 
scar tissue in the affected area, compromises heart function. Therapeutic approaches for 
acquired heart diseases are in crucial need of a sophisticated knowledge about the origin, 
generation and integration of cardiomyocytes. Curative therapies to regain the lost heart 
muscle are not available up to date, but are a topic of ongoing research. 
 
Cardiac development 
At embryonic day (E) 7.0-7.5, cardiac development in mice starts with the formation of two 
groups of cells located on either side of the embryonic midline directly below the head folds 
(Figure 1A). These groups extend across the midline, merge and form the cardiac crescent 
around E7.75. The cardiac cells coalesce in the ventral midline to form a linear heart tube 
until E8.25. It consists only of an endocardial lining and the myocardium, separated by a 
layer of extracellular matrix. From E8.25-10.5, the tubular heart elongates further and 
undergoes a complex looping process to position the atrium and caval veins in a - relative to 
the ventricle - dorso-cranial position. Moreover, the chambers emerge by ballooning out of 
the heart tube and the separation process starts by the formation of endocardial cushions 
and the interventricular septum. Additional remodeling processes result in the formation of 
the four chambered architecture of the mammalian heart (Figure 1).2,3 
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Figure 1 Schematic illustration of murine heart development 
A-D, Anatomical drawings of consecutive stages of cardiac development at E7.75(A), 
E8.25(B), E10.5(C) and E12.5(D). The upper panel shows whole embryos (A, B) and whole 
hearts (C, D) in a ventral view, cranial up. Corresponding sections are depicted below. See 
main text for additional information. avc, atrioventricular canal; avs, atrioventricular septum; 
ca, common atrium; cc, cardiac crescent; cp, cadiac progenitor; dm, dorsal mesocardium; dp, 
dorsal pericardium; e, endocardium; fg, foregut; hm, head mesoderm; ift, inflow tract; ivs, 
inter-ventricular septum; la, left atrium; lv, left ventricle; m, myocardium; ne, neural 
epithelium; oft, outflow tract; ra, right atrium; rv, right ventricle; som, somatic mesoderm; tr, 
trabeculae. Modified from (Stennard FA and Harvey RP,2005)3. 
 
The epicardium: A crucial source of cells and signals 
The early linear heart is a simple tube consisting only of an endocardial lining and the 
myocardium. However at later stages in development the heart comprises a three-layered 
architecture. At that time the myocardium is covered by a mono-layered epicardium, being 
the outermost epithelium of the heart. The epicardium is a derivative of an extracadiac 
precursor cell population, known as the proepicardium. This transitory cell cluster can 
morphologically be identified as cuboidal cells on the sinus horns, facing towards the 
pericardial cavity, when cardiac looping is well under way.4–7 These mesothelium-derived 
cells traverse the pericardial cavity and attach to the myocardium (Figure 2A). This second 
colonization of the heart is a feature found in all vertebrates. Nevertheless, specific 
differences between vertebrate classes can be seen. The process of cell transfer to the heart 
Introduction 
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is either a direct migration onto the heart via a matrix-rich tissue bridge (birds, amphibians 
and the rat)8–10 or a release of free floating vesicles (mouse)5,11,12 which pass the pericardial 
cavity establishing epicardial islands on the surface of the heart. Proliferation and migration 
of these cells results in the formation of a self-contained epicardium (Figure 2B). Underneath 
the epicardium forms a subepicardial mesenchyme, rich in extracellular matrix.13 This 
collagen- and proteoglycan-containing milieu accumulates growth factors and provides a 
basis for the ingrowth of coronary vessels.14,15 Further in development, individual cells of the 
epicardium undergo an epithelial-mesenchymal transition (EMT), leave the epithelial 
contiguity and either populate the subepicardial space or migrate into the compact 
myocardial wall (Figure 3).13,16 During EMT, the cells loose their epithelial characteristics, the 
actin cytoskeleton reorganizes from an epithelial cortical alignment associated with cell-cell 
junctions into actin stress fibers that are anchored to focal adhesion complexes. These cells 
acquire a migratory behavior.17 Mechanical or genetic ablation of the epicardium impairs 
myocardial growth, coronary vessel development and formation of cardiac interstitial 
cells.9,18–22 Thus, the epicardium directly contributes to multiple cardiac lineages through 
EMT. In chick, cell lineage tracing experiments based on retroviral labeling identified smooth 
muscle cells, perivascular and interstitial fibroblasts as epicardium-derived cells 
(EPDCs).10,16,23,24 An additional coronary endothelial fate of EPDCs has been indicated in 
some reports as well.25,26 In mouse, cell lineage tracing analyses revealed contrasting results 
concerning the coronary endothelial fate of EPDCs. Endothelia of the coronary vessels 
where shown to arise from dedifferentiated angiogenic sprouts of the sinus venosus 
endothelium - the vein that returns blood to the embryonic heart. Furthermore, an 
endocardial origin of a subpopulation of coronary endothelia was hypothesized.27Two 
independent lineage tracing studies identified the murine epicardium as a relevant source of 
cardiac muscle for the developing mouse heart. A variable contribution of EPDCs to the 
cardiomyocyte lineage was observed, based on either the Tbx18 or Wt1 regulatory 
sequences, which permanently mark the developing epicardium with a genetic label.28,29 
Intensive epicardial proliferation and incorporation of EPDCs into the regenerating heart of 
zebrafish, which posses the outstanding ability for myocardial regeneration, have positioned 
the epicardium as an attractive potential target for effecting cardiac muscle regeneration.30,31 
Even though this natural regenerative capacity is not present in higher vertebrates, the 
enormous medical interest in a potential myocardial fate of epicardial cells in mammals 
forces to define their contributions in the settings of embryonic heart development and adult 
heart regeneration. 
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Figure 2 Proepicardial cells migrate onto the surface of the embryonic heart. 
Schematic illustrations of (A) an E9.25 embryo, lateral view, and (B) an E9.75 isolated heart; 
dorsal view. The proepicardium (red) provides cells that attach to the surface of the 
embryonic heart at the region of the atrioventricular groove and later migrate until they 
completely cover the heart. ca, common atrium; ift, inflow tract; L, left; lv, left ventricle; oft, 
outflow tract; pe, proepicardium; ph, pharyngeal arches; R, right; rv, right ventricle. 
 
Transcriptional regulation of epicardium development 
The genetic control of epicardial EMT is carefully regulated and several transcription factors 
are expressed in the proepicardium and epicardium. 
Wt1 is expressed in the (pro-)epicardium, the developing genitourinary system, and in the 
mesothelia covering the visceral organs.32 Epicardial EMT is dramatically impaired in Wt1-
null hearts19,33,34 and canonical Wnt signaling was reduced, most likely due to a dysregulation 
of epicardial cell polarity.35 Wt1 inactivation also markedly decreases expression of Raldh2 in 
the epicardium,34,36 and thereby suppresses the differentiation of meschenchymal cells. 
Thus, Wt1 interferes with epicardial EMT.  
Epicardial EMT is also regulated by the transcription factor 21 
(Tcf21/capsulin/Pod1/epicardin). Tcf21 is expressed in mesenchymal cells of the respiratory, 
digestive, urogenital and cardiovascular system.37–40 Tcf21 null embryos fail to develop 
cardiac fibroblasts, as the Tcf21+ subpopulation of epicardial cells cannot undergo EMT.41 
This is the first analysis which points to an epicardial cell fate decision (smooth muscle cells 
vs. fibroblasts) in the epicardium, before the process of EMT. 
The T-box-transcription factor 18 (Tbx18) is expressed in the anterior part of the somites, the 
limb buds, the ureteric mesenchyme, the periotic mesenchyme and the (pro-)epicardium.42–45 
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Interestingly, the transcriptional repressor Tbx18 is dispensable for epicardial development 
and the loss of Tbx18 does not interfere with the mobilization and differentiation of EPDCs.46  
 
Mobilization and differentiation of epicardial cells  
Our knowledge about epicardial development increased in the recent years. Some signaling 
pathways were implicated to be involved in epithelial-mesenchymal transition.  
 
Wnt (wingless-related MMTV integration site) signaling pathways regulate gene expression, 
proliferation, cell fate decisions, and cell polarity during embryonic development. Wnt 
proteins are secreted ligands that bind to Frizzled (Fzd) receptors, thereby stabilizing the 
protein beta-catenin (Ctnnb1). Ctnnb1 is the central mediator of canonical Wnt signaling, 
inducing transcription of target genes (such as Axin2), by forwarding Wnt signals to the 
TCF/LEF (Transcription factor/Lymphoid enhancer-binding factor) complex in the nucleus. 
During heart development, canonical Wnt signaling is tightly controlled to allow specification, 
self-renewal, and differentiation of various cardiac progenitor cell populations.47 
A functional requirement of the canonical (Ctnnb1-dependent) Wnt-signaling pathway in 
epicardial EMT was shown by the paucity of EPDCs in embryos with epicardium-restricted 
Ctnnb1 inactivation.34,48 Ctnnb1 is also an important component of intercellular adhesion 
complexes, and disruption of these complexes may contribute to the loss-of-function 
phenotype. Furthermore, EMT requires Ctnnb1 to establish epicardial cell polarity, direct 
mitotic spindle orientation, and thus interferes with the migratory behavior of EPDCs.35 In 
addition to the reduced mobilization of EPDCs the differentiation of epicardium-derived 
coronary smooth muscle cells was impaired indicating for an involvement of Ctnnb1 in both 
events.48 
 
Pdgfrα (platelet-derived growth factor receptor tyrosine kinase alpha) is important for 
embryonic development; driving the proliferation of undifferentiated mesenchyme, cell 
migration and angiogenesis.49 The epicardium expresses Pdgfrα and a global or epicardium-
restricted inactivation of Pdgfrα results in a cardiac fibroblast formation defect. In addition, 
Pdgfrα mutants show a reduced number of EPDCs within the myocardium, and thus this 
signaling pathway is involved in epithelial-mesenchymal transition.50 
 
Fgfr1 and 2 (fibroblast growth factor receptor 1 and 2) are key players in the processes of 
proliferation and differentiation during embryonic development and often show functional 
redundancy.51 Fgf signaling promotes angiogenesis by endothelial tube formation.52 A 
epicardium-restricted combined inactivation of Fgfr1 and 2 results in a reduced number of 
EPDCs within the myocardium and a reduction in cardiac fibroblasts as well.53 In addition, 
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epicardial and endocardial Fgf signals have been shown to induce the hedgehog signaling 
pathway.54  
 
Hh (Hedgehog) signaling regulates coronary vascular formation and promotes 
neovascularization in the adult heart.54,55 Hh signaling has been shown to promote the 
proliferation of adult stem cells from various tissues.56,57 All three ligands (sonic, desert, 
indian hedgehog) are interchangeable, bind to the patched-receptors and induce the unique 
downstream effector smoothened (Smo). Epicardium-derived Fgf-signals have been shown 
to induce sonic hedgehog (Shh) signaling. Hh signaling to cardiomyoblasts is required for the 
development of coronary veins, while Hh signaling to perivascular cells is necessary for 
coronary arterial growth.58  
The Notch signaling pathway is an important mediator of proliferation, stem cell 
maintenance, cell fate decisions and boundary formation in the development and 
homeostasis of various tissues.59 Ligand binding to the Notch receptor releases the active 
Notch intracellular domain (NICD). NICD translocates to the nucleus where its binding to the 
transcription factor recombination signal binding protein for immunoglobulin kappa J region 
(Rbpj) displaces co-repressor complexes from this DNA-binding factor. Notch signaling has 
been associated with angiogenic growth of the blood vessels, arterial versus venous fate 
decisions, and vascular smooth muscle cell differentiation.60 Furthermore, Notch1ICD is 
expressed in the (pro)epicardium, in forming coronary smooth muscle cells and endothelia of 
chicken embryos;61 thereby suggesting a functional relevance in the developing murine 
epicardium. 
 
The study of epicardial EMT revealed extensive signaling events in heart development and 
reiteration of these pathways might result in acquired heart diseases. In modern medicine the 
heart is easily accessible and drugs can be delivered directly to the epicardium. Therapeutic 
manipulations of epicardial cells are already tested in vivo. The G-actin monomer binding 
protein thymosin beta 4 (TB4) has been shown to reduce infarct size in experimental 
myocardial infarction62. Based on the possible potential of fetal EPDCs to differentiate into 
cardiomyocytes and modulation of epicardial activity by TB4, epicardial cells might represent 
a resident cardiac progenitor pool that could be recruited for therapeutic myocardial 
regeneration.  
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Figure 3 Molecular pathways in the mobilization and differentiation of epicardial cells. 
Individual cells of the epicardium (green) undergo an EMT, leave the epithelial contiguity and 
migrate into the myocardial wall. Signaling pathways implicated in either effecting 
mobilization and differentiation (blue arrows) or differentiation (red arrows) of epicardial cells. 
ec, endothelial cell; EPDC, epicardium-derived cell; epi, epicardium. 
 
 
Mesothelia in development and homeostasis 
The epicardium is an epithelium of mesodermal origin, thus correctly named a mesothelium. 
The mesothelium is the epithelial lining of mesodermic cavities. It develops from the 
mesoderm layer that lines the body cavity (coelom) of the early developing embryo.63 
Mesothelia form a monolayer of flattened, squamous-like cells, located on a thin basement 
membrane. They line the pleural and pericardial cavities of the chest, and the peritoneal 
cavity of the abdomen. The body wall is lined by the parietal mesothelium, whereas the 
visceral layer covers the organ in the respective cavity.64 
In the adult, mesothelial cells secrete gycosaminogycans and surfactant to provide a 
frictionless free surface between the parietal and visceral layer.65 During development single 
cells are able to leave the mesothelium, undergo a epithelial-mesenchymal transition and 
invade the underlying tissue. This feature is not only restricted to the epicardium, but 
mesothelium-derived fibroblasts and smooth muscle cells have been detected in the 
developing gut and lung as well.16,23,66–69 
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In various areas, including the adult omentum and the embryonic proepicardium, cuboidal 
mesothelial cells can be found.70,4 Interestingly, the morphology of these precursor cells 
resembles cells that can be detected at the sides of injury in mesothelial tissues.71 
Additionally, it was suggested that free-floating mesothelial cells implant into the side of 
injury,72 thus wound repair in these tissues might reflect a re-initiation of the embryonic gene 
program. In recent years the visceral pericardium, also known as epicardium, was in the 
focus of several studies addressing its potential function in the regenerative capacity of the 
heart. New insights into the function of mesothelial cells in homeostasis and repair might 
promote regenerative applications in the future. 
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Aim of the Thesis 
 
The epicardium, the outermost lining of the heart, provides trophic signals and cells to the 
developing coronary vasculature and the fibrous heart skeleton. Genetic lineage tracing 
approaches in different model organisms provided conflicting results on the fate of 
epicardium-derived cells in embryonic development. Furthermore, the signaling pathways 
that mediate mobilization and differentiation of these cells have been only insufficiently 
defined. Tracing and manipulation of epicedium-derived cells in mouse can be performed 
using specific cre-lines.  
In this thesis, the suitability of Wt1cre and Tbx18cre mouse lines for these purposes should be 
tested. Furthermore, an adequate line should be used for lineage tracing of epicardial cells 
by means of a sensitive reporter allele in vivo. In addition, signaling pathways effecting the 
mobilization and differentiation of epicardium-derived cells will be analyzed. Conditional 
alleles of unique mediators of the Notch-, canonical Wnt-, Hh-, Fgfr1/2- and Pdgfrα-signalling 
pathways will be crossed to the Tbx18cre mouse line to test for their functional relevance in 
epicardial development in vivo. Furthermore, misexpression of constitutive active Wnt- and 
Hh- signaling in the epicardium should be analyzed.  
Finally, mice, with genetically ablation of Upk3b were to be generated and analyzed for 
cellular and molecular changes in the urothelium and epicardium.  
Together this study should provide us with unambiguous knowledge about the fate of 
epicardium-derived cells and should give more insights into signaling pathways effecting the 
mobilization and differentiation of epicardium-derived cells. 
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Tbx18 and the fate of epicardial progenitors
Arising from: C.-L. Cai et al. Nature 454, 104–108 (2008)
Uncovering the origins of myocardial cells is important for under-
standing and treating heart diseases1,2. Cai et al.3 suggest that Tbx18-
expressing epicardiumprovides a substantial contribution tomyocytes
in the ventricular septum and the atrial and ventricular walls. Here we
show that the T-box transcription factor gene 18 (Tbx18) itself is
expressed in the myocardium, showing that their genetic lineage
tracing system does not allow conclusions of an epicardial origin of
cardiomyocytes in vivo to be drawn.
During amniote embryogenesis, cells from the proepicardium, a
mesothelial cell cluster located at the venous pole of the heart, emigrate
onto the myocardium to form the epicardium—the epithelial outer
lining of the heart. Lineage-tracing studies in chick demonstrated that
epicardial cells invade the myocardium, giving rise to coronary
vascular support cells and adventitial fibroblasts4–6.
In mouse, genetic lineage studies can be used to assess the contri-
bution of precursor cells to a mature tissue or organ7. For the proepi-
cardium/epicardium, such an effort has nowbeenundertaken byCaiet
al.3 based on the observation that the transcription factor geneTbx18 is
expressed at high levels in these embryonic tissues8.Using a knock-in of
the Cre recombinase gene in the Tbx18 locus, epicardial cells were
labelled irreversibly and their daughters were followedduring develop-
ment. The authors found that, in addition to known fates, Tbx18-
positive epicardial cells contributed to the myocardium of the inter-
ventricular septum (IVS) and myocardial wall. Clearly, such a finding
would define the epicardiumas a previously unknownprogenitor pool
of cardiomyocytes complementing the earlier contributions of the first
and second heart field9.
Prerequisite to any genetic lineage study is the specificity of the
gene that drives Cre recombinase. In this specific case, Tbx18 (Cre)
should not be expressed in the myocardium. In previous studies, we
observed robust Tbx18 expression in the IVS and left ventricular wall
at embryonic day (E)12.5 (refs 10, 11). Further analysis revealed
continuous Tbx18 expression in the IVS and the myocardium of the
left ventricle from E10.5 to at least E16.5 (Fig. 1a–d, f, g). Tbx18
expression co-localized withmyocardial (Tnni3) staining on adjacent
sections (Fig. 1e). Immunofluorescent analysis using an anti-Tbx18
antibody confirmed that Tbx18 protein is continuously expressed in
the IVS and the left ventricular cardiomyocytes (Nkx2-5-positive)
from E10.5 onwards (Fig. 1i–m). Detection of pre-messenger RNA
in epicardium-free IVS myocardium tissue obtained by laser capture
microdissection from E11.5 wild-type hearts confirmed that Tbx18
expression is initiated de novo in cardiomyocytes (Fig. 1h). A protein
kinase C iota (Prkci) null mutant (a gift from M. Leitges), which
completely fails to form epicardium around the ventricles and dies
at E12.5, expressed Tbx18 in the IVS in a pattern similar to that in
control embryos (Fig. 1n–q), further demonstrating that Tbx18
expression in the myocardium of the IVS and left ventricle is
independent from that in the epicardium.
We have generated a Cre knock-in allele of Tbx18 (Tbx18Cre), the
Cre activity pattern of which faithfully reflects endogenous Tbx18
expression8 (Fig. 2a). Comparison of expression of Tbx18 from the
wild-type allele and lacZ from the R26RlacZ reporter12 on adjacent
sections of hearts of Tbx18Cre/1;R26RlacZ embryos showed overlap of
the Cre recombination pattern (lacZ expression) and endogenous
Tbx18 in the epicardium and in the IVS and left ventricular wall
(Fig. 2b, c). Furthermore, we observed unchanged Cre activity from
the Tbx18Cre allele in the left ventricle and the septum region in mice
mutant for theWilms tumor 1 (Wt1) gene13 (Fig. 2d, e). Formation of
epicardium and subepicardial mesenchyme is severely compromised
in these mice14, again indicating that myocardial Tbx18 expression is
independent from the presence and functionality of the epicardium.
Together, our results unambiguously show that Tbx18 expression is
also present in cardiomyocytes of the IVS and the ventricular wall
from E10.5 onwards.
The failure of Cai et al. to detect expression of Tbx18 in the myo-
cardium may result from lack of sensitivity in their expression assays
and tools (nlacZ/nGFP knock-in allele)3. Their Tbx18Cre allele is likely
to be active in cardiomyocytes, similar to our Tbx18Cre allele, but its
pattern may be affected by the presence of the PGK-neo cassette3
(compare dissimilarity in recombination in somites and head region
in Fig. 2b in ref. 3 and Fig. 2a here), which could lead to ectopic Cre
activity in the heart. A genetic lineage study similar to that in ref. 3,
following the fate of Wt1Cre-expressing epicardium, also indicated
that epicardium differentiates to myocardium15. Our analysis,
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Figure 1 | Expression of Tbx18 is not confined to the epicardium but is also
found in cardiomyocytes of the interventricular septum and the left
ventricle. a–g, Section in situ hybridization analysis forTbx18 (a–d, f, g) and
cardiac troponin I (Tnni3, e) expression on paraffin sections of E10.5
(a, b), E11.5 (c–e), E14.5 (f) and E16.5 (g) hearts. Insets (a, c) are magnified
(b, d). h, Pre-mRNA of Tbx18 is detected in laser-captured epicard-free IVS
from E11.5 wild-type (WT) hearts by RT–PCR analysis for intron 1
sequences (lane 2). Background signal is observed in tissue from the right
ventricle of the samehearts (lane 3). KO, knockout. i–m, Immunofluorescent
analysis of Tbx18 protein expression on paraffin sections of E10.5 (i), E11.5
(j, l, m) and E14.5 (k) hearts. Coexpression analyses of Nkx2-5 (yellow
nuclei, white arrows in i–k). Absence of Tbx18 protein signals in sections of
Tbx18GFP/GFP hearts (m). n–q, Section in situ hybridization analysis ofTbx18
mRNA (n, o) and immunofluorescent analysis of Tbx18 protein (p, q) in
E12.5 Prkci mutant hearts that lack an epicardium (o, q). avc,
atrioventricular cushion tissue; en, endocardium; ep, epicardium; ivs,
interventricular septum; la, left atrium; lv, left ventricle; ra, right atrium; rsh,
right sinus horn; rv, right ventricle. Scale bars: 100mm (a–g, n–q); 25 mm
(i–m).
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which shows that the genetic lineage study by Cai et al.3 does not
unequivocally demonstrate an epicardial origin of cardiomyocytes
in vivo, supports the notion that independent approaches are required
to assess the relationship of a specific progenitor cell to a specific
differentiated cell type.
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We recognized the importance of confirming data from Cre lineage
studieswith an alternative approach, and thus used a fluorescent dye to
lineage-label epicardial cells. This approach confirmed that epicardial
cells contributed tomyocytes within the heart1. In our experiments, we
never observedTbx18mRNAwithin ventricles at embryonic day E10.5
to E11.5, although our RNA signal in epicardium at these stages is at
least as strong as that observed by Christoffels et al.2. We note a
discrepancy between amount of RNA staining (broadly throughout
the middle of the ventricle) and protein staining (much more
restricted) that Christoffels et al.2 observe at early stages. Reasons for
discrepancies between our RNA in situ data and that of Christoffels
et al. are unclear. Christoffels et al.2 detectTbx18 intronic sequences by
RT–PCRof E11.5 IVS, but do not provide data to demonstratemature
Tbx18 mRNA. Notably, we did observe active expression of Tbx18 in
non-myocytes after E11.5 (ref. 1).
Expression of Tbx18:nlacZ in our experiments is consistent with
our RNA in situ data for Tbx18. Despite overstaining, and examina-
tion of multiple hearts and sections, Tbx18:nlacZ was not expressed
within the heart at E10.5 and E11.5—times at which we observed
lineage-traced Tbx18:Cre myocardial cells1. Immunostaining for
b-galactosidase (b-gal) protein was consistent with X-gal data.
Why there are differences between these data and the Christoffels
et al.2 Tbx18 immunostaining data is unclear. Tbx18 antibody stain-
ing in heart by Christoffels et al.2 demonstrates much lower levels of
positive staining for Tbx18 within heart (barely above background)
than in epicardium (in which it is robust). Data presented on
Prkci2/2 mutants are difficult to comment on, as this model has
not been described in the literature. Published Prkci2/2 mutants
do not survive after E9.5 (ref. 3). At E12.5, we also observe active
expression of Tbx18:nlacZ within the heart, but have found that
actively expressing cells are non-myocytes. Christoffels et al. do not
address the cell type observed in Prkci mutants.
With regard to Tbx18 lineage studies in the Wt1 mutant back-
ground, it is important to consider that the Wt1 mutant phenotype
is variable and dependent on strain background4. Mutants can die as
early as E12.5 or survive throughout gestation. Even on an inbred
C57/BL6 background, lethality occurs over a relatively broad window
from E12.5 to E15 (refs 4–6). Even in themost severely affected cases,
the epicardium forms throughout much of the heart (see Fig. 2b of
ref. 6), including the caudal region adjacent to the septum and the left
ventricle, and entry of epicardial cells into the heart is observed in
regions of interventricular and atrioventricular sulci6. InWt1mutant
a b c
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Figure 2 | Cre activity from a Cre-knock-in allele of Tbx18 (Tbx18Cre)
recapitulates endogenous Tbx18 expression. Tbx18Cremice were crossed to
R26RlacZ indicator mice12 and expression and activity of the reporter was
detected in compound Tbx18Cre/1/R26RlacZ embryos. a, X-gal (5-bromo-4-
chloro-3-indolyl-b-D-galactoside) staining on a whole-mount E10.5 embryo
faithfully reflects endogenous Tbx18 expression8. b, c, Section in situ
hybridization analysis on adjacent paraffin sections of E14.5 hearts shows
complete overlap of Tbx18 (b) and lacZ reporter gene (c) expression.
d, e, X-gal staining for Tbx18-driven Cre activity on transverse cryo-sections
from E12.5 hearts of wild-type embryos (d) and a homozygous mutant for
Wt1 (e, ref. 14). The formation of the epicardium (arrows) is severely
compromised in mutants. asm, anterior somite halves; lsh, left sinus horn.
Other abbreviations are as in Fig. 1. Scale bars, 100mm (b–e).
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Cellular Biology
Notch Signaling Regulates Smooth Muscle Differentiation of
Epicardium-Derived Cells
Thomas Grieskamp, Carsten Rudat, Timo H.-W. Lu¨dtke, Julia Norden, Andreas Kispert
Rationale: The embryonic epicardium plays a crucial role in the formation of the coronary vasculature and
in myocardial development, yet the exact contribution of epicardium-derived cells (EPDCs) to the vascular
and connective tissue of the heart, and the factors that regulate epicardial differentiation, are
insufficiently understood.
Objective: To define the role of Notch signaling in murine epicardial development.
Methods and Results: Using in situ hybridization and RT-PCR analyses, we detected expression of a number of
Notch receptor and ligand genes in early epicardial development, as well as during formation of coronary
arteries. Mice with epicardial deletion of Rbpj, the unique intracellular mediator of Notch signaling, survived to
adulthood and exhibited enlarged coronary venous and arterial beds. Using a Tbx18-based genetic lineage tracing
system, we show that EPDCs give rise to fibroblasts and coronary smooth muscle cells (SMCs) but not to
endothelial cells in the wild type, whereas in Rbpj-deficient embryos EPDCs form and surround the developing
arteries but fail to differentiate into SMCs. Conditional activation of Notch signaling results in premature SMC
differentiation of epicardial cells and prevents coronary angiogenesis. We further show that Notch signaling
regulates, and cooperates with transforming growth factor ! signaling in SM differentiation of EPDCs.
Conclusions: Notch signaling is a crucial regulator of SM differentiation of EPDCs, and thus, of formation of a
functional coronary system. (Circ Res. 2011;108:813-823.)
Key Words: Tbx18 ! Tgfb ! Pdgfrb ! coronary ! smooth muscle cell
The epicardium, the outermost layer of the heart, developsafter cardiac looping from a cluster of mesothelial cells
of the septum transversum region at the cardiac venous pole.
From embryonic day (E)9.0 on in the mouse, cells of this
proepicardial organ (PEO) float through the pericardial space,
adhere to the myocardium, spread out and form a continuous
epithelial layer around E10.5. A subset of these epicardial
cells undergoes an epithelial–mesenchymal transition (EMT),
migrates into the subepicardial space or invades the underly-
ing myocardium.1 Cell lineage tracings mainly done in the
chick have shown that subepicardial mesenchyme further
differentiates in interstitial and perivascular fibroblasts, in
smooth muscle cells (SMCs) and coronary endothelial
cells.2,3 Genetic fate-mapping studies in the mouse suggested
that a substantial fraction of cardiomyocytes may also derive
from epicardial cells.4,5 Besides its role as cell source for the
coronary vasculature and the myocardium, the embryonic
epicardium acts as a center of paracrine signals that promote
the maturation of other cardiac components including the
embryonic myocardium. The genetic pathways that regulate
the different steps of epicardial development are insuffi-
ciently understood.1
The Notch signaling pathway is an evolutionarily con-
served regulator of local cell–cell interactions that mediate
cell fate decisions, proliferation, apoptosis, boundary forma-
tion, and stem cell maintenance in a variety of tissues in
development and homeostasis.6 In mammals, 4 different
transmembrane Notch receptors (Notch1 to -4) and 5 differ-
ent transmembrane ligands (Delta-like [Dll]1, -3, -4; Jagged
[Jag]1, -2) have been identified. Binding to a ligand on an
adjacent cell induces 2 consecutive proteolytic cleavages of
the Notch receptor to release the active Notch intracellular
domain (NICD). NICD translocates to the nucleus, where its
binding to the transcription factor recombination signal bind-
ing protein for immunoglobulin kappa J region (Rbpj) dis-
places corepressor complexes from this DNA-binding factor.
Coactivators are recruited instead and transcription of target
genes including members of the basic helix-loop-helix hairy/
enhancer-of-split related with YRPW motif gene family
(Hey1, Hey2, HeyL) is initiated.6 Notch signaling has been
implicated in numerous processes in cardiovascular develop-
ment including endocardial cushion formation, maturation of
the ventricular myocardium, establishment of atrioventricular
canal boundaries, arterial-venous fate decisions, angiogenic
Original received July 21, 2010; revision received January 5, 2011; accepted January 11, 2011. In December 2010, the average time from submission
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growth of the blood vessel network, proliferation of endothe-
lial cells and vascular SMC differentiation.7,8 Expression of
the Notch1ICD in mesothelial cells of the PEO and the
epicardium, in nascent vessels, and in both endothelial and
surrounding smooth muscle cells of the coronary arteries in
the developing chick heart9 suggested an additional role of
this pathway in the developing epicardium.
Here, we analyze the role of Notch signaling in epicardial
development by genetic loss- and gain-of-function experi-
ments in the mouse. We show that Notch signaling regulates
SM differentiation of EPDCs, and we define the epistatic
relation with other signaling pathways implicated in coronary
arteriogenesis.
Methods
Animal care was in accordance with national and institutional
guidelines. Mice carrying a null allele of Rbpj (Rbpjtm1.1Hon, syn-
onym: Rbpjflox),10 mice with an integration of the intracellular
domain of the Notch1 receptor gene in the Rosa26 locus
(Gt(ROSA)26Sortm1(Notch1)Dam, synonym: Rosa26NICD),11 and mice
with an insertion of the cre recombinase gene in the Tbx18 locus
(Tbx18tm4(cre)Akis, synonym: Tbx18cre)12 and the fluorescent reporter
line (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J, synonym:
Rosa26mTmG)13 were all described previously. All mouse lines were
maintained on an outbred (NMRI) background.
An expanded Methods section is available in the Online Data
Supplement at http://circres.ahajournals.org.
Results
Multiple Notch Receptors and Ligands Are
Expressed During Development of the Epicardium
and the Coronary System
To determine the temporal and spatial involvement of Notch
signaling in mouse epicardial and coronary vessel develop-
ment, we analyzed expression of genes encoding Notch
receptors and ligands, and target genes of the Hey family by
in situ hybridization from onset of (pro-)epicardial develop-
ment at E9.5 to E18.5 when a functional coronary system has
been established (Online Figure I). In whole E9.5 embryos,
we detected strong expression of Hey1, weak expression of
Jag1 and very weak expression of Notch1, Notch2 and
Notch3 in the PEO (Figure 1A). Expression of Notch2 and
Notch3, Dll3, Hey1, Hey2 and HeyL was found in the
epicardium at E10.5 (Figure 1B). Semiquantitative RT-PCR
analysis on epicardial cell cultures confirmed transcription of
these genes and provided evidence for additional expression
of Jag1 (Figure 1C). At E12.5 and later, expression of Notch
pathway components was no longer found in the epicardium
by in situ hybridization analysis. However, starting from
E12.5 we detected expression of these genes in the subepi-
cardial space and the underlying myocardium indicating an
association with EPDCs and the forming coronary system. At
E12.5, Notch1 and Dll4 were expressed in individual cells in
the subepicardial mesenchyme, most likely representing en-
dothelial cells of the sprouting coronary plexus (Figure 1D).
Hey2 expression was too prominent in the ventricular myo-
cardium to distinguish an additional expression in the devel-
oping coronaries (Online Figure I). At E14.5, expression of
Notch pathway constituents became more complex in the
subepicardial region. We found expression of Notch1,
Notch3, Dll4, Jag2, Hey1 and HeyL in endothelial and
associated perivascular cells (Figure 1E). At E18.5, expres-
sion of Notch components was exclusively associated with
large coronary arteries that were distinguished by a larger
lumen and the deep location from the smaller veins that were
located subepicardially. Notch1 was coexpressed with Notch3
and HeyL in the outer ring of perivascular cells. In the inner
endothelial layer Notch1 was coexpressed with Dll1 (very
weakly), Dll4, Jag1, Jag2 and Hey1 (Figure 1F; Online
Figure I). Thus, Notch expression (and signaling) occurs in a
biphasic manner in epicardial development. First, in the PEO
and early epicardium, later in EPDCs and/or endothelial cells
during coronary artery formation.
Loss of Rbpj-Dependent Notch Signaling in the
PEO and Epicardium Results in Severe
Morphological Defects of the
Coronary Vasculature
Given the complexity of Notch receptor and ligand expres-
sion during development of the epicardium and the coronary
system, we assumed that redundancy between receptors and
ligands, respectively, may necessitate the simultaneous re-
moval of 2 or more genes to assign a Notch signaling
requirement to these processes. We therefore decided to
analyze the phenotypic consequences of removal of Rbpj that
encodes a unique intracellular mediator of (canonical) Notch
signaling.14 Because Rbpj-deficiency results in early embry-
onic lethality in mice,15 we used a tissue-specific inactivation
approach using a Tbx18cre line generated in our laboratory
and a floxed Rbpj allele to analyze Notch signaling function
in the PEO and epicardium.10,12 The T-box transcription
factor gene Tbx18 is strongly expressed in the PEO at E9.5,
and in the epicardium until E16.5. Other cardiac expression
domains include the sinus horn mesenchyme/myocardium,
and the myocardium of the left ventricle and the interventric-
ular septum (IVS) (Online Figure II, A).16,17 We used
Rosa26mTmG reporter mice13 to demonstrate that cre expres-
Non-standard Abbreviations and Acronyms
cSMC coronary smooth muscle cell
DAPI 4,6-diamidino-2-phenylindol
Dll Delta-like
E embryonic day
EMT epithelial–mesenchymal transition
EPDC epicardium-derived cell
Hey hairy/enhancer-of-split related with YRPW motif
IVS interventricular septum
Jag Jagged
NICD Notch intracellular domain
Pdgfrb platelet-derived growth factor receptor ! polypeptide
PEO proepicardial organ
Rbpj recombination signal binding protein for immunoglobulin "J
region
SM smooth muscle
SMC smooth muscle cell
Tgfb transforming growth factor !
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sion from the Tbx18 locus mediates recombination in all
known Tbx18 expression domains and their cellular descen-
dants in whole E9.5 and E10.5 embryos, and in the heart from
E9.5 to E14.5 in a faithful manner (Online Figure II, B and
C). In the Rosa26mTmG reporter line recombination is visual-
ized by bright membrane bound GFP expression in a back-
ground of membrane bound red fluorescence. Anti-GFP immu-
nofluorescence analysis on sections of Tbx18cre/!;
Rosa26mTmG/! hearts provides additional cellular resolu-
tion of cre recombination events.13
To our surprise, Tbx18cre/!;Rbpjflox/flox mice survived to 6
months of age without any obvious external defects. Hearts of
3-month-old mice had a normal shape but featured grossly
abnormal coronary vessels with a dramatically enlarged
vascular bed on their surface (Figure 2A). Histological
sections revealed that the lumen of deeper vessels was
increased as well albeit less dramatically compared to sub-
epicardial vessels. Intramyocardial and subepicardial location
suggested these vessels to be of arterial and venous identity,
respectively.18 We confirmed this notion by detecting expres-
sion of the venous and capillary marker endomucin (Emcn)19
in the epithelial lining of these inflated vessels underneath the
surface but not in the deeper intramyocardial vessels where
the pan-endothelial marker Pecam1 indicated the presence of
an endothelium (Figure 2A). To exclude that these coronary
changes are merely a physiological adaptation to (unknown)
stress but represent the consequences of a developmental
defect, we analyzed mutant hearts during embryogenesis.
Morphological and histological inspection revealed the pres-
ence of size increased intramyocardial and largely inflated
superficial vessels in the Tbx18cre/!;Rbpjflox/flox heart at
E18.5. Emcn was again expressed in the endothelial linings of
the superficial but not the deep vessels. Emcn staining also
revealed reduction of intramyocardial capillaries suggesting
that large coronary arteries and veins are expanded at the
expense of these smaller vessels (Figure 2B). Arterial mark-
ers ephrin B2 (Efnb2), Dll1 and vascular endothelial growth
factor A (Vegfa)20 were expressed in the endothelium of the
intramyocardial but not the superficial vessels whereas nu-
clear receptor subfamily 2, group F, member 2 (Nr2f2) was
found in nuclei of venous but not of arterial endothelial cells
(Figure 2C). In sections of E14.5 Tbx18cre/!;Rbpjflox/flox
hearts, the distribution and size of coronary vessels appeared
relatively unaffected, and Emcn staining was not different
from the wild type (Online Figure III). Thus, epicardial loss
of Rbpj results in severe morphological changes of the
coronary vasculature after onset of coronary circulation at
E15.5. However, these changes are not caused or associated
with an arterial-venous switch of coronary endothelial
identity.
Rbpj-Dependent Notch Signaling Is Required for
SM Differentiation of EPDCs
We next analyzed whether changes in identity or integrity of
the epicardium, formation of subepicardial mesenchyme
and/or subsequent differentiation of EPDCs may explain the
observed defects in the coronary vascular system. In E14.5
Tbx18cre/!;Rbpjflox/flox embryos, histological analysis con-
firmed the integrity of the epicardial epithelium (Online
Figure III). Expression of epicardial marker genes Wilms
Figure 1. Expression of genes encoding
Notch receptors, ligands, and targets in epi-
cardial development. A through F, Expression
of Notch receptor (Notch1–4), Notch ligand
(Dll1, Dll3, Dll4, Jag1, Jag2), and Notch target
gene expression (Hey1, Hey2, HeyL) by in situ
hybridization analysis of whole hearts (A) and
on sections of the left ventricle (B and D
through F) at the indicated stages and by
semiquantitative RT-PCR analysis (C) in epicar-
dial explant cultures. Semiquantitative RT-PCR
analysis was performed on water control (neg),
on E16.5 embryonic lungs as positive control
(pos), and on a pool of epicardial explants
(exp). Long arrows in D indicate expression in
subepicardial cells. Short arrows in E point to
forming coronary vessels. Schemes in D
through F depict subepicardial vessel forma-
tion with endothelial cells (green) and perivas-
cular cells (red) that are associated with
expression of Notch pathway genes. a indi-
cates atrium; avc, atrioventricular canal; ca,
coronary artery; cv, coronary vein; endo, endo-
cardium; epi, epicardium; eth, endothelium; lv,
left ventricle; myo, myocardium; peo, proepi-
cardial organ; sm, smooth muscle cell layer;
sub, subepicardial space.
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tumor 1 homolog (Wt1), transcription factor 21 (Tcf21),
Tbx18, fibulin 2 (Fbln2), aldehyde dehydrogenase family 1,
subfamily A2 (Aldh1a2) was unchanged confirming that
epicardial cells retained their normal identity. Expression of
Wt1 and Tcf21 was also found in subepicardial cells indicat-
ing that epicardial EMT occurred and EPDCs migrated into
the subepicardial space and the myocardium (Online Figure
IV). To further analyze the fate of epicardial cells, we
performed Tbx18cre based genetic lineage tracing in wild-type
and Rbpj mutant background using the Rosa26mTmG reporter
line. Anti-GFP immunofluorescence on sections of E14.5
wild-type hearts labeled epicardial cells, thin and slender cells
in the right ventricular myocardium, and cells surrounding
superficial veins and deeply located arteries. A similar situ-
ation was found in Tbx18cre/!;Rbpjflox/flox hearts at this stage
confirming that loss of epicardial Rbpj function does not
affect epicardial EMT and EPDC immigration (Figure 3A).
Double immunofluorescence analysis for expression of Gfp
and markers for arterial endothelial cells (nitric oxide syn-
thase 3 endothelial cell [Nos3]), venous endothelial cells
(Emcn), SMCs (actin !2 smooth muscle, aorta, Acta2, also
known as SMaActin), prospective SMCs (Notch3), fibro-
blasts (periostin [Postn]), and cardiomyocytes (cardiomyo-
cyte-specific troponin I cardiac 3,Tnni3, and myosin heavy
chain cardiac muscle [Myhc]) confirmed that in wild-type
conditions, EPDCs differentiated into fibroblasts and SMCs
but not into endothelial cells (Figure 3B through 3D). Not a
single cardiomyocyte in the right ventricle was GFP positive
(Figure 3E) (in the left ventricle, endogenous myocardial
expression of Tbx18 does not allow such an analysis).17
However, differentiation of epicardium derived perivascular
cells into SMCs selectively failed in Tbx18cre/!;Rbpjflox/flox
hearts (Figure 3C). Notably, Notch3 was still expressed in
perivascular cells arguing that Notch3 expression is indepen-
dent from Notch signaling but that it is required for SMC
differentiation in coronary arteries (Figure 3C; Online Figure
V). Thus, epicardial cells contribute to intramyocardial and
perivascular fibroblasts, to coronary SMCs (cSMCs) but not
to coronary endothelial cells. Rbpj-dependent Notch signaling
is selectively required for differentiation of perivascular cells
into SMCs. Changes of coronary morphology at later stages
are a likely secondary physical consequence of the loss of the
arterial SM coating.
Figure 2. Defects of the coronary vascula-
ture in mice with epicardial deletion of Rbpj.
A through C, Analysis of coronary vessel for-
mation in Tbx18cre/!;Rbpjflox/flox mice by mor-
phology of whole hearts, by hematoxylin/eosin
staining and by immunofluorescence for endo-
thelial marker proteins on transverse cardiac
sections at 3 months of age (A) and at E18.5
(B and C). C, Higher magnifications of individ-
ual coronary arteries and veins. Emcn stains
endothelia of large veins and capillaries; Dll1,
Efnb2, and Vegfa stain arterial endothelia; and
Nr2f2 stains nuclei of venous endothelial cells.
Rectangles in images of whole hearts are
magnified in the images to the right. Arrows
point to the endothelial lining of superficially
located venous coronary vessels; arrowheads
point to the arterial endothelial lining. endo indi-
cates endocardium; epi, epicardium; lcv, left
caval vein; lv, left ventricle; rv, right ventricle.
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Notch Signaling Is Sufficient to Induce Premature
SM Differentiation of Epicardial Cells
Because our loss-of-function analysis showed that Notch
signaling is required for SM differentiation of EPDCs, we
wondered whether premature activation of the pathway in
vivo might actually be deleterious for epicardial develop-
ment. We achieved (pro-)epicardium specific activation of
the pathway by Tbx18cre mediated expression of the Notch1
intracellular domain (NICD) from a Rosa26 knock-in allele
(Rosa26NICD).11 Tbx18cre/!;Rosa26NICD/! mice died shortly
after E14.5 exhibiting edema formation and bleeding. Mor-
phological inspection of the mutant hearts revealed local
protrusions of the epicardium (Figure 4A). On histological
sections, the epicardium appeared discontinuous, and a thick
subepicardial matrix with intermingled mesenchymal cells
detached the epicardium from the underlying myocardium.
The myocardial compact layer was severely reduced in
thickness (Figure 4B). Epicardial expression of Tbx18, Wt1
and Aldh1a2 was discontinuous and/or reduced (Figure 4C).
Expression of SM myosin heavy chain (smMHC), HeyL,
Hey2, and Notch3 was found in the epicardium but not in the
subepicardium, intramyocardially, or in perivascular loca-
tions (Figure 4D; Online Figure VI). Gfp expression from the
Rosa26mTmG reporter in the Tbx18cre/!;Rosa26NICD/! back-
ground was present in epicardial membranes but only in few
subepicardial cells in the right ventricular myocardium (Fig-
ure 4E). This suggests that premature SM differentiation of
epicardial cells prevents their immigration into the subepicar-
dial space and the myocardium. Emcn expression was re-
stricted to the endocardium, and venous endothelium in the
atrial-ventricular groove region but did not extend subepicar-
dially or intramyocardially toward the apex as in the wild
type (Figure 4F).
We traced the developmental onset of these epicardial
defects by analyzing Tbx18 and Acta2 expression at earlier
stages. Tbx18 expression was present in the PEO at E9.5. In
contrast to the wild-type situation, myocardial colonization
by Tbx18-positive epicardial cells was severely delayed, and
SM differentiation of epicardial cells prematurely induced in
Tbx18cre/!;Rosa26NICD/! embryos at E12.5 (Figure 5A
through 5D). Expression of integrin !4 (Itga4) that is re-
quired for myocardial attachment of epicardial cells,21 and of
Sox9 was downregulated in the E9.5 PEO (Figure 5E through
5G), explaining delayed myocardial colonization. Together,
this analysis shows that (pro-)epicardial activation of Notch1
signaling leads to defects in the formation and differentiation
of the epicardium that affect coronary plexus formation and
myocardial growth.
SM Differentiation of Primary Epicardial Cells by
NICD Overexpression
To obtain more detailed insight into the cellular and molec-
ular consequences of epicardial activation of Notch signaling,
Figure 3. Disrupted cytodifferentiation of
EPDCs in Tbx18cre/!;Rbpjflox/flox mice. A,
Analysis of formation and migration of
EPDCs in Tbx18cre/!;Rosa26mTmG/!;
Rbpjflox/flox mice by immunofluorescence of
the Gfp reporter on transverse sections of
the whole E14.5 heart and on a higher
magnification of the right ventricle (white
rectangles). B through E, Analysis of
cytodifferentiation of EPDCs by double im-
munofluorescence of the Gfp reporter
(green) and markers (in red) for arterial en-
dothelial cells (Nos3), venous endothelial
cells (Emcn) (B), SMCs (Acta2), prospective
SM cells (Notch3) (C), fibroblasts (Postn)
(D), and cardiomyocytes (Tnni3, Myhc) (E)
on serial transverse sections of the
right ventricle of E18.5 Tbx18cre/!;
Rosa26mTmG/!;Rbpjflox/flox hearts. Nuclei are
counter-stained with DAPI. Arrows point to
the endothelial lining of enlarged superfi-
cially located venous coronary vessels;
arrowheads point to the arterial endothelial
lining. epi indicates epicardium; lsh, left
sinus horn; lv, left ventricle; rv, right
ventricle.
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we analyzed cultures of highly enriched primary epicardial
cells (Figure 6). These were obtained from right ventricular
explants at E11.5. After 2 days in serum-free medium the
outgrowth of wild-type ventricles presented as a monolayer
of tightly packed hexagonal cells. Expression of the tight
junction protein 1 (Tjp1, also known as ZO1) confirmed the
epithelial character of these cells. Tbx18 was predominantly
and Wt1 exclusively localized to the nucleus suggesting that
these cells represent indeed epicardial “precursor” cells.
Transgelin (Tagln), Acta2, and Notch3 were expressed at
very low levels; Pecam1 was not expressed, confirming that
these epicardial cells have not differentiated into the SM or
endothelial cell lineage. In contrast, explants of Tbx18cre/!;
Rosa26NICD/! hearts provided a cellular outgrowth with a
rugged front line, and cells with a more mesenchymal
appearance and reduced cell contacts. Tjp1 was absent from
the membrane but localized throughout the cytoplasm. Tbx18
expression was downregulated whereas Wt1 was redistrib-
uted from the nucleus to the cytoplasm. SM markers (Acta2,
Tagln, and Notch3) were highly upregulated. Pecam1 expres-
sion was absent in these outgrowths (Figure 6A). Prolifera-
tion was not statistically affected by NICD overexpression
(Figure 6B). The molecular changes were enhanced after 2
additional days of serum-free culture after removal of the
ventricle (Online Figure VII). These results clearly show that
NICD is sufficient to induce mesenchymal transition and SM
differentiation of epicardial cells but does not affect cell
proliferation.
Notch Signaling Acts Upstream of Tgfb Signaling
and Pdgfrb in EPDCs
Previous work identified a requirement of transforming
growth factor ! (Tgfb) and platelet-derived growth factor !
receptor (Pdgfrb) signaling in SM differentiation during
coronary arteriogenesis in the mouse.22,23 To analyze the
epistasis between these pathways and Notch signaling, we
determined whether expression of the intracellular mediator
of Tgfb signaling, activated P-Smad2,3, and of Pdgfrb is
affected by epicardial loss- or gain-of Notch signaling. In
hearts of E18.5 Tbx18cre/!;Rbpjflox/flox embryos, both
P-Smad2 and -3 and Pdgfrb expression was specifically
absent from perivascular cells of coronary arteries (Figure
7A). In contrast, expression of both proteins was induced in
epicardial cells of Tbx18cre/!;Rosa26NICD/! embryos at E14.5
(Figure 7B). Furthermore, semiquantitative RT-PCR analysis
revealed twofold induction and reduction, respectively, of
Pdgfrb mRNA expression in epicardial explant cultures of
NICD-overexpressing and Rbpj-deficient hearts, respectively
(Figure 7C). Together, these data show that Notch signaling
is required and sufficient to induce Tgfb signaling and Pdgfrb
expression in epicardium and EPDCs.
Notch Cooperates With Tgfb Signaling in inducing
SM Genes in EPDCs
We further analyzed the interplay between these signaling
pathways in epicardial explant cultures by scoring mRNA
expression of the 2 smooth muscle marker genes Acta2 and
Tagln by semiquantitative RT-PCR after different pharmaco-
logical treatments in wild-type and mutant backgrounds
(Figure 8; Online Table I). TGFb1 induced SM marker gene
expression in wild-type epicardial cultures. The inhibitor of
Tgfb receptor 1 (Alk5) SB431542 but also PDGF-BB abro-
gated this effect (Figure 8A). Expression of SM marker genes
was similarly induced in NICD-expressing epicardial ex-
plants but could not be further enhanced by additional TGFb1
Figure 4. Disrupted epicardial development in mice overex-
pressing the Notch1 intracellular domain. A through E, Anal-
yses were performed on E14.5 wild-type (wt) and Tbx18cre/!;
Rosa26NICD/! embryos for epicardial integrity and differentiation
by morphological inspection of whole hearts (A), by hematoxy-
lin/eosin staining (B) (arrows in A and B point to epicardial blis-
ters), by immunofluorescence of expression of Tbx18, Wt1, and
smMHC, and by in situ hybridization of Aldh1a2, HeyL, and
Notch3 expression on transverse sections of the right ventricle
(C and D). E, Cell lineage tracing by anti-Gfp immunofluores-
cence on sections of the right ventricle in Tbx18cre/!;
Rosa26NICD/mTmG embryos. F, Emcn immunofluorescence to
reveal the integrity of the coronary plexus. White arrows mark
the restricted angiogenic sprouts of the coronary plexus close
to the atrioventricular groove region. Rectangles mark the
regions that are magnified in the images to the right. c indicates
compact layer; endo, endocardium; epi, epicardium; ivs, inter-
ventricular septum; la, left atrium; lv, left ventricle; rv, right
ventricle.
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in the medium. Tgfb1-inhibitor and PDGF-BB both inhibited
NICD-activated SM gene expression, suggesting that Tgfb
signaling acts downstream of Notch signaling to induce SM
differentiation (Figure 8B). Remarkably, TGFb1 was not
sufficient to rescue loss of SM gene induction in absence of
Notch signaling (in Rbpj-deficient cultures), arguing for
cooperativity between these 2 pathways in SMC differentia-
tion (Figure 8C). NICD expression strongly induced expres-
sion of Tgfb1–3, interestingly, again in a Tgfb-signaling–
dependent manner (Figure 8D). Together, these in vitro
experiments argue that Notch signaling induces Tgfb signal-
ing by upregulating Tgfb-ligands. Notch and Tgfb signaling
then cooperatively induce SM differentiation of EPDCs.
Discussion
The embryonic epicardium is a crucial cell source for the
developing heart, yet the derived cell types, and the signals
and factors that control their differentiation are incompletely
understood. Here, we have shown by genetic experiments in
vivo that cardiac fibroblasts and coronary SMCs derive from
the epicardium, and that the canonical Notch pathway in
conjunction with Tgfb signaling controls SM differentiation
of EPDCs.
Fate of Epicardial Cells
Lineage studies in avian species originally demonstrated that the
(pro-)epicardium is a source for cardiac fibroblasts and coronary
vascular progenitors including mural and endothelial cells.2,3,24
Genetic fate-mapping studies in the mouse questioned the
epicardial origin of coronary endothelial cells but suggested that
a subset of cardiomyocytes are epicardium derived. In fact, Cai
et al reported that a substantial fraction of cardiomyocytes of the
left ventricle and the IVS derive from Tbx18-positive epicardial
cells,4 whereas 7% to 18% ventricular, atrial and IVS cardio-
myocytes were noted as descendants of Wt1-positive epicardial
cells in another study.5 Although a critical reevaluation of the
Wt1-based epicardial lineage tracing has not yet been published,
we have previously raised concerns on the validity of the
Tbx18cre approach based on the endogenous expression of
Tbx18 in cardiomyocytes of the IVS and left ventricle from at
least E10.5 in development.17 The Tbx18cre line used in our
study allowed faithful activation of cre in all Tbx18 domains.
Our experiments did not identify cardiomyocytes in the right
ventricle to derive from the overlying epicardium questioning
the results by Zhou et al.5 We neither detected endothelial cells
to be of epicardial origin corroborating a recent report that the
coronary plexus develops by angiogenic sprouting of the sinus
venosus region of the postlooped heart.25 Decisive clarity on the
definitive spectrum of epicardial fates requires additional exper-
imental testing using independent genetic tracing systems that
are based on genes selectively and exclusively expressed in the
PEO/epicardium. Until this point, fibroblasts and SMCs may be
considered as the 2 major if not exclusive cellular derivatives of
the (pro-)epicardium in mammals.
Notch Signaling and cSMC Differentiation
Our expression analysis identified Notch expression and signal-
ing in the PEO and epicardium, and in EPDCs and associated
endothelial cells of the forming coronary vasculature.
Characterization of mice with epicardial loss of Rbpj did
not uncover phenotypic changes that would support a role
for canonical Notch signaling in epicardium formation,
Figure 5. Early onset of epicardial
defects in Tbx18cre/!;Rosa26NICD/!
embryos. A through D, Immunofluores-
cence analysis of Tbx18 protein expres-
sion (in red) in sections of whole hearts at
E9.5 (A), E10.5 (B), E12.5 (C) and in a
subregion of the right ventricle at E12.5
(D). White arrows point to clusters of
Tbx18-positive epicardial cells. Acta2
expression by immunofluorescence
(green in D) is only present in the myo-
cardial layer in the wild-type, whereas
epicardial cells coexpress Tbx18 and
Acta2 protein at this stage in the mutant.
E through G, In situ hybridization analysis
of Sox9 and Itga4 expression on saggital
sections (E and F) and of Itga4 in whole
E9.5 hearts (G). Black arrows indicate
reduced expression of Sox9 and Itga4 in
the mutant PEO. Genotypes are as indi-
cated. a indicates atrium; avc, atrioven-
tricular canal; epi, epicardium; lv, left ven-
tricle; oft, outflow tract; peo, proepicardial
organ; rv, right ventricle.
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epicardial EMT, or fibroblast differentiation. In fact,
forced epicardial expression of NICD led to defects of
myocardial colonization and epicardial differentiation that
strongly argue against Notch function at these stages of
epicardial development. However, Notch signaling was
specifically required for cSMC differentiation. Restricted
expression of Notch1 and Notch3 in perivascular cells and
of Jag1, Jag2, Dll1, and Dll4 in endothelial cells of
coronary arteries suggests that multiple Notch ligands
activate a redundant pair of Notch receptors in mural cells
in trans. Notch ligand–receptor interaction may be addi-
tionally involved in the initial recruitment of EPDCs to
arterial endothelial cells.26 Expression of Notch3 in these
cells was maintained, suggesting that ligand–receptor in-
teraction mediates adhesion of the 2 cell types in an
Rbpj-independent fashion. It also shows Notch3 expres-
sion in these cells is independent from Notch signaling.
Loss of Rbpj in cSMC cells did not change the identity of
coronary arterial endothelial cells in our mice. Hence,
establishment and maintenance of arterial endothelial fate
is independent of a functional SM coating as suggested by
analysis of mice with endothelial specific loss of Jag-
ged1.27 Most likely, it is mediated by endothelial expres-
sion of Notch1, Dll1 and Dll4 as shown for large systemic
arteries.20,28
Although the role of Rbpj in cSMCs had not been charac-
terized before, the functional implication of canonical
Notch signaling in the SM phenotype of perivascular cells
of the systemic circulation was well known.8,29 In fact,
Notch1, Notch3, and Jag1 were identified as crucial
Figure 6. Induction of SM differentiation
of primary epicardial cells by NICD over-
expression. A, Cellular analysis of epicar-
dial outgrowths of explants of right ventri-
cles of wild-type (wt) and Tbx18cre/!;
Rosa26NICD/! embryos after 2 days of cul-
ture under serum-free conditions by bright
field morphology, and immunofluorescent
analysis of the tight junction protein Tjp1
(ZO1); epicardial transcription factors Wt1
and Tbx18; smooth muscle proteins Acta2,
Tagln, and Notch3; and endothelial Pecam1.
Shown are whole explants (bright field,
Acta2, Tagln, Notch3, and Pecam1) and/or
magnified regions (white rectangles) with
nuclear counter-staining (DAPI) from the
epicardial outgrowth only. Red spots occa-
sionally found in the Pecam stainings are
likely to present endocardial contaminants
or unspecific staining of cell debris. B, Anal-
ysis of cell proliferation in epicardial
explants by the bromodeoxyuridine (BrdU)
incorporation assay, with quantification of
bromodeoxyuridine-positive cells (wild type,
19.6"5.5%; NICD, 20.9"4.4%, P#0.733).
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perivascular-endothelial receptors and ligand, respec-
tively, in this tissue context as well. Hence, Notch signal-
ing is likely to be a common regulator of SMC differen-
tiation of perivascular cells independent from their
developmental origin.
Notch Regulates and Cooperates With Tgfb
Signaling in SM Differentiation of EPDCs
Previous work has established that canonical Wnt, Tgfb, and
Pdgf signaling are required in vivo for formation of coronary
SMCs from epicardial precursors. The Pdgfr pathway was
implicated in proliferation and EMT of epicardial cells,23 Wnt
signaling in oriented epicardial cell division,30,31 and Tgfb
signaling both in epicardial EMT and later in SM differenti-
ation of perivascular cells.22,32 Although our analysis has not
addressed interaction between Notch and Wnt signaling, we
have shown that Notch pathway activation is required and
sufficient for induction of Tgfb signaling and Pdgfrb expres-
sion in epicardial cells in vivo. Pdgfrb was reported as an
immediate target of Notch function in vascular SMCs33 but
regulation of Tgfb signaling by Notch has only been noted in
SM differentiation of mesenchymal stem cells34 and in
myofibroblast differentiation of alveolar epithelial cells.35
Our findings suggest that NICD induction of Tgfb signaling
in EPDCs is mediated by robust activation of Tgfb1–3
transcription, similar to the findings in cultures of alveolar
cells.35 Tang and coworkers recently demonstrated that Notch
and Tgfb1 cooperatively activate SMC marker transcripts and
Figure 7. Tgfb signaling and Pdgfrb are downstream of the
Notch pathway in SM differentiation of epicardial cells. A
and B, Comparative immunofluorescence analysis of expression
of P-Smad2, -3, Tagln, and Pdgfrb (red fluorescence) in coro-
nary arteries of the right ventricle of wild-type (wt) and Tbx18cre/!;
Rbpjflox/flox embryos (A) and in epicardial and subepicardial cells
in wild-type and Tbx18cre/!;Rosa26NICD/! embryos (B) at E14.5.
Green fluorescence for collagen IV allows visualization of the
basement membrane underlying endothelial and epicardial cells
(white arrowheads) and, thus, to delineate epicardium from
underlying myocardium. Blue fluorescence marks DAPI-stained
nuclei. Note absence of red fluorescence in epicardial cells in
wild-type hearts. C, Semiquantitative RT-PCR analysis of Pdgfrb
expression in pools of epicardial explants derived from wild-type
(wt), Tbx18cre/!;Rosa26NICD/! (NICD), and Tbx18cre/!;Rbpjflox/flox
(Rbpj) hearts. NICD: 2.1"0.42,P#0.06; Rbpj: 0.49"0.04;
P#0.007. Figure 8. Notch and Tgfb signaling cooperate in SM differ-
entiation of EPDCs. A through C, Semiquantitative RT-PCR
analysis of Acta2 and Tagln expression in differently treated
pools of epicardial explants derived from wild-type (A), Tbx18cre/!;
Rosa26NICD/! (B), and Tbx18cre/!;Rbpjflox/flox (C) embryos. D,
Induction of Tgfb1–3 in wild-type, Rbpj-deficient, and NICD-
expressing epicardial explants under the indicated conditions.
For values and statistical significance see Online Table I.
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protein in primary human SMCs through parallel signaling
axes.36 Our failure to rescue SMC differentiation of primary
epicardial cells by Tgfb1 clearly indicates that a similar
cooperativity exists in EPDCs. Interestingly, Rbpj can di-
rectly activate transcription of the SMC marker Acta2.37 Rbpj
also binds and stabilizes P-Smad2/3 at Smad consensus
binding sites within promoters of SM genes,36 suggesting that
molecular complex formation on adjacent DNA binding sites
in promoters of SM genes as the basis for pathway
cooperativity.
PDGF-BB efficiently inhibited induction of SM gene
expression by Notch and Tgfb1 signaling in epicardial cells.
The molecular mechanism of this inhibitory effect is unclear,
but it suggests that Pdgfr signaling actively maintains the
precursor character of EPDCs. Together, our findings support
the model that Notch signaling activates and cooperates with
Tgfb signaling to induce differentiation of vascular SMC
from different progenitor pools. Pdgfrb is regulated by Notch
signaling as well but may locally modulate or inhibit this
differentiation program.
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Novelty and Significance
What Is Known?
● The embryonic epicardium is a source of trophic signals for the
myocardium and a cellular source for the coronary vasculature
and the fibrous skeleton of the heart.
● Notch signaling is a crucial regulator of common vasculogenesis.
● Transforming growth factor (TGF)-! and platelet-derived growth
factor (PDGF) signaling regulate smooth muscle (SM) differentia-
tion of epicardium-derived cells (EPDCs).
What New Information Does This Article Contribute?
● In the mouse, the epicardium is a cellular source for cardiac
fibroblasts and SMCs of the coronary arteries but not of cardio-
myocytes and coronary endothelia.
● Notch pathway constituents are expressed during epicardial devel-
opment.
● Rbpj-dependent Notch signaling is required for SMC differentiation of
EPDCs in vivo.
● Notch signaling is sufficient to induce premature SMC differentiation
of epicardial cells in vivo.
● Notch signaling acts upstream of TGF-! signaling and PDGFR-!
expression in SMC differentiation of EPDCs.
● Notch and TGF-! signaling cooperate in SMC differentiation of
EPDCs.
● PDGF signaling antagonizes Notch and TGF-!–induced SMC differ-
entiation of EPDCs.
Coronary artery disease is a leading cause of death worldwide.
The cellular and molecular programs that direct the formation of
a functional coronary vasculature from simple precursors tissues
are, however, only poorly understood. Here, we have identified
fibroblasts and SMCs as the 2 cellular lineages derived from the
epicardium and have uncovered Notch signaling as a major
pathway required for SM differentiation of EPDCs in the mouse.
Our study shows that epicardium is unlikely to be a cellular
source of coronary endothelia, but that epicardial-derived sig-
nals play a crucial role in formation and elaboration of the
coronary plexus. We identify TGF-! signaling as a downstream
cooperator of Notch signaling in the development of the SM
coating of the coronary arteries. Our results provide novel insight
into the genetic and cellular pathways regulating the formation
of the coronary vasculature that may aid in developing novel
therapeutic avenues for cellular regeneration after coronary
heart disease.
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Supplemental Online Materials and Methods
Mice and genotyping
Embryos for Notch expression analysis were derived from matings of NMRI wild-type mice.
Tbx18cre/+;Rbpjflox/flox mice were obtained from matings of Tbx18cre/+;Rbpjflox/+ males and
Rbpjflox/flox females. Single heterozygous littermates were used as controls for mutant
embryos. Tbx18cre/+;Rosa26NICD/+ mice were obtained from matings of Tbx18cre/+ males and
Rosa26NICD/NICD females. The fate of epicardial cells was analyzed in Tbx18cre/+;Rosa26mTmG/+
embryos (obtained from matings of T b x 1 8cre/+ and R o s a 2 6mTmG/mTmG mice), in
Tbx18cre/+;Rosa26mTmG/+;Rbpjflox/flox embryos  (ob ta i ned  f r om ma t i ngs  o f
Tbx18cre/+;Rosa26mTmG/+;Rbpjf l o x / +  males and Rbp jf l o x / f l o x  females)  and in
Tbx18cre/+;Rosa26NICD/mTmG mice (obtained from matings of Tbx18cre/+;Rosa26mTmG/+ males and
Rosa26NICD/NICD females. For timed pregnancies, vaginal plugs were checked in the morning
after mating, noon was taken as embryonic day (E) 0.5. Embryos were harvested in PBS,
fixed in 4% paraformaldehyde overnight and stored in 100% methanol at –20oC before
further use. Wildtype littermates were used as controls. Genomic DNA prepared from yolk
sacs or tail biopsies was used for genotyping by PCR (protocols upon request). H. Hedrich,
state head of the animal facility, approved the care of animals and experiments at
Medizinische Hochschule Hannover.
Epicardial cell culture
To obtain cultures of primary epicardial cells, E11.5 hearts were dissected and half of one
right ventricle plated onto a gelatin-coated dish in serum-free DMEM supplemented with
2mM Glutamax, 100 units/ml Penicillin, 100 µg/ml Streptomycin (Gibco). Epicardial cells
migrated from the ventricle onto the dish and formed an epithelial monolayer. After 2 days,
the ventricle was carefully removed using forceps. The highly enriched epicardial cells were
further cultured in DMEM/Panserin401 with or without 10% FCS, 250 pM recombinant
human TGFb1 (#100-21, PeproTech or R&D Systems), recombinant human PDGF-BB
(250pM, Cell Signaling) and the Tgf receptor 1 (Alk5) inhibitor SB431542 (2.5 µM, Sigma).
Histological analysis
For histological stainings embryos were fixed in 4% paraformaldehyde, paraffin embedded,
and sectioned to 4 or 10 µm. Sections were stained with haematoxylin and eosin, following
standard procedures.
Semi-quantitative reverse Transcription PCR
For expression analysis of Notch pathway components 18 wildtype (NMRI) epicardial cell
cultures were pooled. We used E16.5 embryonic lungs as a positive control in this
experiment since this tissue is known to express all Notch pathway components.
1-3 For
analysis of smooth muscle differentiation 2-4 cultures were combined. 2-5 individual pools of
each experiment were used for RT-PCR analysis.
Total RNA was extracted with RNAPure reagent (Peqlab) and DNaseI treated for 30min at
37°C. RNA was reverse transcribed with RevertAid H-minus M-MuLV Reverse Transcriptase
(Fermentas). For semi-quantitative PCR, the number of cycles was adjusted to the mid-
logarithmic phase. Quantification was performed with Quantity One software (Bio-Rad).
Normalization was against Gapdh. Assays were performed at least twice in duplicates. P-
values were calculated using the unpaired two tailed Student's t-Test. Primers and PCR
conditions are available on request.
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In situ hybridization analysis
In situ hybridization analysis of whole embryos and of sections with digoxigenin-labeled
antisense riboprobes followed published protocols.4,5 Details of used probes upon request.
Immunodetection of proteins
For immunohistochemistry rabbit polyclonal antibody against Wt1 (1:200, C-19, Santa Cruz),
goat polyclonal antibody against Tbx18 (1:200, C-20, Santa Cruz), rabbit polyclonal antibody
against ZO1 (Tjp1) (1:200, 61-7300, Zymed Laboratories Inc.), monoclonal antibody against
CD31 (Pecam1) (1:50, 550274, BD Pharmingen), rabbit polyclonal antibody against GFP
(1:200, sc-8334, Santa Cruz), monoclonal antibody against GFP (1:200, 11814460001,
Roche), goat polyclonal antibody against P-Smad2/3 (Ser433/435) (1:50, sc-11769, Santa
Cruz), monoclonal antibody against alpha-Smooth muscle actin (Acta2), Cy3 Conjugate
(1:200, C 6198, Sigma), monoclonal antibody against alpha-Smooth muscle actin (Acta2),
FITC Conjugate (1:200, F3777, Sigma), goat polyclonal antibody against cardiac troponin I
(Tnni3) (1:200, 4T21/2, HyTest), monoclonal antibody against heavy chain cardiac myosin
(Myhc) (1:200, ab15, Abcam), rabbit polyclonal against SM22alpha (TagIn) (1:200, ab14106,
Abcam), goat polyclonal antibody against ephrinB2 (Efnb2) (1:200, AF496, R&D Systems),
monoclonal antibody against CoupTFII (Nr2f2) (1:100, PP-H7147-10, R&D Systems), rat
monoclonal antibody against endomucin (Emcn) (1:2, a kind gift of D. Vestweber, MPI
Münster; Germany), rabbit polyclonal antibody against Notch3 (1:200, ab23426, Abcam),
rabbit polyclonal antibody against periostin (Postn) (1:50, ab14041, Abcam), rabbit polyclonal
antibody against Delta-like1 (Dll1) (1:100, H-265, sc9102, Santa Cruz), rabbit polyclonal
antibody against Vegf (Vegfa) (1:100, sc-507, Santa Cruz), rabbit polyclonal antibody against
eNos (Nos3) (1:200, Affinity BioReagents), rabbit polyclonal antibody against bovine aortic
smooth muscle myosin (BASM, smooth muscle myosin heavy chain 204/200, smMHC)
(1:200, a kind gift of R. Adelstein, Bethesda, USA), rabbit polyclonal antibody against
collagen type IV (1:200, #AB756P, Millipore Corp.) and rabbit monoclonal antibody against
Pdgf receptor beta (1:100, #3169, Cell Signaling) were used as primary antibodies. Alexa488
goat-anti-rabbit (Invitrogen, 1:250), Alexa488 donkey-anti-mouse (Invitrogen, 1:200),
Rhodamin goat-anti-rabbit (Dianova, 1:200), Red-X donkey-anti-mouse (Dianova, 1:200), R-
PE em575 swine-anti-goat (Invitrogen, 1:200), biotinylated donkey-anti-goat (Dianova,
1:200), biotinylated goat-anti-mouse (Dianova, 1:200), biotinylated goat-anti-rat (Dianova,
1:200), DyLight 488-conj. Fab fragment donkey-anti-rabbit (Dianova, 1:200) and biotinylated
goat-anti-rabbit (Dianova, 1:200) were used as secondary antibodies. Nuclei were stained
with 4,6-Diamidino-2-phenylindol (DAPI) (Roth). For antibodies against Tbx18, P-Smad2/3,
Efnb2, Emcn, Notch3, Postn, Dll1, Vegfa, Nr2f2, Nos3 and Pdgf receptor beta, paraffin
sections were pressure cooked for 3 min in antigen unmasking solution (H-3300, Vector
Laboratories Inc). The signal was amplified using the Tyramide Signal Amplification (TSA)
system from Perkin-Elmer (NEL702001KT, Perkin Elmer LAS). For double staining with GFP,
secondary antibody was added during the biotinylated secondary antibody step of the TSA
protocol.
Proliferation assay
Epicardial cell cultures obtained from explants of E11.5 right ventricles were incubated for 4h
with BrdU (5-Bromo-2´-deoxyuridine, 0,05 mg/ml) and fixed in methanol. Cultures were
treated with mouse-on-mouse blocking reagent according to the manufacturer (VectorLabs)
before the antigen was detected by successive incubations with anti-BrdU antibody (1:200,
Roche), biotinylated anti-mouse IgG (Vector-Labs), and VectastainABC (VectorLab) reagent.
The detection reaction was performed using diaminobenzidine and hydrogen peroxide as
substrates. Nuclei were stained with 4,6-Diamidino-2-phenylindol (DAPI) (Roth). The BrdU-
labeling rate was defined as the number of BrdU-positive nuclei relative to the total number
of nuclei as detected by DAPI counterstain on four epicardial explant cultures each of
wildtype and Tbx18
cre/+
;Rosa
26NICD/+ hearts. The mean values and standard deviation were
determined and the Student’s t-test was performed to test for statistical relevance.
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Documentation
Sections and Immunofluorescence were photographed using a Leica DM5000 microscope
with Leica DFC300FX digital camera. Immunofluorescence of cells was documented using a
Leica DMI6000B microscope with Leica DFC350FX. All images were processed in Adobe
Photoshop CS.
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Supplemental Online Figures
Online Figure I. Multiple genes encoding Notch receptors and ligands as well as Notch
target genes are expressed in epicardial development. In situ hybridization analysis of Notch
receptor (Notch1-4), Notch ligand (Dll1, Dll3, Dll4, Jag1 , Jag2) and Notch target gene
expression (Hey1, Hey2, HeyL) in the whole hearts of E9.5 embryos (first column), and in the
E10.5 epicardium, in subepicardial cells at E12.5, in forming coronary vessels at E14.5, and
in coronary arteries at E18.5 on transverse sections of the heart. Black rectangles indicate
the region shown in higher magnification images to the right. This analysis reveals two waves
of Notch expression and Notch signaling during epicardial development, from E9.5 to E10.5
in the proepicardium and early epicardium; from E12.5 onwards in endothelial and
perivascular cells of the forming coronary arteries. a, atrium; avc, atrioventricular canal; ca,
coronary artery; endo, endocardium; epi, epicardium; eth, endothelium; ivs, interventricular
septum; myo, myocardium; lv, left ventricle; peo, proepicardial organ; rv, right ventricle; sm,
perivascular smooth muscle cell layer; sub, subepicardial space.
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Online Figure II. Tbx18cre mice - a tool for visualization, and manipulation and tracing of
epicardial cells by genetic recombination. (A) In situ hybridization analysis of Tbx18
expression during murine heart development. Tbx18  expression is detected in the
proepicardial organ at E9.5, and from E10.5 to E14.5 in the epicardium, the sinus horns, the
interventricular septum and the left ventricular myocardium. (B) Comparison of Tbx18
expression in whole E9.5 and E10.5 embryos as detected by in situ hybridization analysis
and GFP reporter fluorescence in whole Tbx18cre/+;Rosa26mTmG/+ embryos of the same
stages. The Rosa26mTmG reporter provides red fluorescence in unrecombined cells, and
green fluorescence after cre mediated recombination. Note the perfect overlap of Tbx18
expression and GFP activity from the reporter. (C) Anti GFP immunofluorescence on
sections of the developing heart at the indicated stages from Tbx18cre/+;Rosa26mTmG/+
embryos. Note the perfect match of GFP and Tbx18 expression as shown in (A) and the
presence of epicardium-derived cells in the right ventricular myocardium at E14.5. White
rectangles indicate areas of the heart that are magnified in the images to the right. a, atrium;
avc, atrioventricular canal; cm, cranial paraxial mesoderm; epi, epicardium; h, heart; im,
intermediate mesoderm; ivs, interventricular septum; li, limb bud; lv, left ventricle; peo,
proepicardial organ; ra, right atrium; rv, right ventricle; sh, sinus horn; so, somite.
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Online Figure III. Coronary endothelia are not affected by epicardial loss of Rbpj at E14.5.
Histological analysis by haematoxylin/eosin (HE-) staining and immunofluoresence analysis
of endomucin (Emcn) expression of transverse sections of wildtype (wt) and
Tbx18cre/+;Rbpjflox/flox hearts show that subepicardial blood vessels are distributed normally at
this stage. endo, endocardium; epi, epicardium; lv, left ventricle; rv, right ventricle.
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Online Figure IV. Loss of Rbpj does not affect epicardial identity and integrity. In situ
hybridization analysis of epicardial marker genes in transverse section of the heart of E14.5
wildtype (wt) and Tbx18cre/+;Rbpjflox/flox embryos. Epicardial expression of all marker genes is
maintained in the mutant. a, atrium; epi, epicardium; ivs, interventricular septum; lv, left
ventricle; rv, right ventricle.
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Online Figure V. cSMCs are absent in hearts with epicardial loss of Rbpj. (A-F)
Immunofluorescence analysis of Acta2 and Notch3 expression in transverse heart sections
of wildtype (wt) and Tbx18cre/+;Rbpjflox/flox embryos at E18.5. (A,D) Overview of the heart with
white rectangles to indicate the magnified region. (B,C,E,F) Magnified images of coronary
arteries. Acta2 expression is completely lost in the mutant, whereas Notch3 is still found in
cells surrounding coronary arterial endothelial cells. lv, left ventricle; rv, right ventricle.
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Online Figure VI. Epicardium specific activation of Notch signaling in
Tbx18cre/+;Rosa26NICD/mTmG embryos. Analysis of expression of Notch target genes Hey1,
Hey2, HeyL and Notch3 in hearts of E14.5 wildtype (wt) and Tbx18cre/+;Rosa26NICD/mTmG
embryos by in situ hybridization analysis on transverse sections. Hey2, HeyL and Notch3 are
specifically induced in the epicardium of Tbx18cre/+;Rosa26NICD/mTmG hearts (arrows).
Rectangles indicate regions that are magnified in the images on the right side.
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Online Figure VII. NICD expression induces SM differentiation of epicardial cells. Cellular
analysis of epicardial outgrowths of explants of right ventricles of wildtype (wt) and
Tbx18
cre/+
;Rosa26
NICD/+ embryos. After two days of culture under serum-free conditions in
DMEM the ventricle was removed and the culture continued for two more days in 50%
DMEM/50%Panserin under serum-free conditions. Immunofluorescence analysis of
expression of the smooth muscle proteins Acta2, the tight junction protein Tjp1 (ZO1), and
the epicardial transcription factors Wt1 and Tbx18. Shown are whole explants and magnified
regions (white rectangles) with nuclear counterstaining (DAPI). Acta2 expression is
upregulated and relocalized from the cortical region into stress fibers, Tjp1 is localized from
the cell membranes into the cytoplasm, Tbx18 is lost and Wt1 relocalized to the cytoplasm in
epicardial cells overexpressing NICD. Together, this shows that epicardial cells underwent
EMT and differentiated into SMCs.
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Tagln Acta2 Tagln Acta2 Tagln Acta2
wt 1.00 ± 0.16 1.00 ± 0.46
wt + TGFb1 1.60 ± 0.23 3.01 ± 0.99 0.0004 0.0011
wt + SB431542 0.38 ± 0.23 1.03 ± 0.16 0.0126 0.9231 0.0014 0.0377
wt + TGFb1 + SB431542 0.99 ± 0.26 1.44 ± 0.49 0.9307 0.2932 0.0190 0.0836
wt + PDGF-BB 1.04 ± 0.24 1.00 ± 0.23 0.7130 0.9939
wt + TGFb1 + PDGF-BB 0.85 ± 0.29 1.47 ± 0.54 0.2764 0.1036
NICD 2.18 ± 0.49 2.73 ± 0.63 0.0010 0.0049
NICD + TGFb1 1.69 ± 0.08 2.81 ± 0.96 0.0005 0.0036 0.1792 0.9293
NICD + SB431542 0.72 ± 0.47 1.26 ± 0.47 0.2028 0.4115 0.0437 0.0385
NICD + PDGFBB 0.85 ± 0.25 0.63 ± 0.18 0.2490 0.1216 0.0038 0.0385
NICD + TGFb1 + PDGF-BB 1.05 ± 0.54 1.44 ± 0.67 0.8328 0.3219 0.1595 0.1856
Rbpj mut 1.01 ± 0.55 0.56 ± 0.14 0.9701 0.1555
Rbpj mut + TGFb1 1.32 ± 0.47 0.75 ± 0.18 0.3593 0.4018 0.6997 0.2263
Rbpj mut + PDGFBB 0.69 ± 0.12 1.12 ± 0.37 0.0455 0.7527 0.6806 0.0837
Rbpj mut + TGFb1 + PDGF-BB 0.96 ± 0.20 0.99 ± 0.29 0.7792 0.9785 0.9453 0.1030
Tgfb1 Tgfb2 Tgfb3 Tgfb1 Tgfb2 Tgfb3
wt 1.00 ± 0.12 1.00 ± 0.13 1.00 ± 0.52 - - -
wt + TGFB1 1.72 ± 0.53 1.68 ± 1.11 3.76 ± 1.48 0.1817 0.0190 0.0090
NICD 4.25 ± 0.61 16.89 ± 5.53 23.03 ± 4.95 0.0367 0.0199 0.0179
NICD + SB431542 1.11 ± 0.46 4.13 ± 2.28 6.75 ± 4.75 0.7454 0.0282 0.0539
Rbpj mut 1.14 ± 0.08 0.91 ± 0.38 0.83 ± 0.53 0.4106 0.8439 0.6765
Rbpj mut + TGFb1 1.55 ± 0.45 0.94 ± 0.73 2.19 ± 0.27 0.0790 0.9511 0.3894
Tgfb1 Tgfb2 Tgfb3 Tgfb1 Tgfb2 Tgfb3
wt not determined not determined
wt + TGFb1 not determined not determined
NICD not determined not determined
NICD + SB431542 0.0045 0.0053 0.0115 not determined
Rbpj mut not determined not determined
Rbpj mut + TGFb1 not determined 0.0440 0.9681 0.2181
Online Table I. The table contains mean values and standard deviations (SD) as well as calculated P-values for Fig. 8. Values refer 
to indicated columns of the graph. Statistical significance is assumed if the P-value is below 0.05. Significant changes are indicated 
in bold.
mean ± SD P-value compared with wt P-value compared with wt + TGFb1
P-value compared with NICD
P-value compared with Rbpj mut
P-value compared with Rbpj mutP-value compared with NICD
not determined
not determined
not determined
P-value compared with wtmean ± SD
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Methods
Mice and Genotyping
Mice with a knock-in of the cre recombinase gene in the Wt1
locus (Wt1tm1(EGFP/cre)Wtp or Wt1creEGFP),9 mice with a knock-in
of the tamoxifen inducible cre-recombinase in the Wt1 locus
(Wt1tm2(cre/ERT2)Wtp or Wt1creERT2),9 and the double fluorescent
cre reporter line (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J or
Rosa26mTmG)15 were obtained from the Jackson Laboratory (Bar
Harbor, ME). All mice were maintained on an outbred (NMRI)
background. Animal care was in accordance with national and
institutional guidelines. Detailed Methods are provided in the
Online Supplement.
Results
Wt1 Expression in the Heart Is Not Restricted to
Epicardial Cells
Genetic lineage tracing by the cre/loxP technology relies on
the fact that cre is expressed only in the precursor tissue but
not in the differentiated cell type for which contribution
should be tested. For Wt1-based epicardial fate mapping
systems, it requires that Wt1 is expressed in the (pro)epicar-
dium but not in any other cell type of the developing and
mature heart. Cardiac expression of Wt1 has been reported for
the (pro)epicardium, but also for cells of unknown nature in
the subepicardium and the interventricular septum,16 –18
prompting us to reinvestigate Wt1 expression during cardiac
development (Figure 1).
In situ hybridization analysis on embryo sections did not
detect Wt1 mRNA in E8.5 hearts (Online Figure I). At E9.5,
strong Wt1 expression was found in the proepicardium and in
the few epicardial cells that have settled onto the myocardium
in the atrioventricular sulcus. At E14.5, the entire epicardial
layer was positive for Wt1, as were individual cells in the
interventricular septum and in the subepicardium and myo-
cardium of the ventricles (Figure 1A, B).
Cardiac expression of Wt1 protein was not found in E8.5
embryos by immunofluorescence analysis (Online Figure I).
At E9.5, high levels of Wt1 protein were confined to nuclei of
the proepicardium and the first epicardial cells in the sulcus
region. Weak Wt1 expression was occasionally observed in
nuclei of the myocardium and endocardium (Figure 1C). At
E14.5, all epicardial cells were positive for nuclear Wt1
protein, whereas in the interventricular septum the subepicar-
dium and myocardium of the ventricles individual Wt1-
positive cells were detected. Expression in the myocardium
occurred mostly in tight association with luminal spaces
(Figure 1D). Coexpression of Wt1 and the endothelial marker
isolectin B419 at E9.5 and E14.5 confirmed endogenous
expression of Wt1 in endothelial cells of the endocardium
and/or of the coronary vasculature (Figure 1E–G). Because of
technical constraints (antibodies against Wt1 and the two
well-established nuclear myocardial marker proteins Nkx2.5/
Prox1 were all raised in rabbits), it was not possible to
unambiguously demonstrate that Wt1! isolectin B4" cells in
the E9.5 myocardium and the E14.5 subepicardium (open
triangle in Figure 1E, F) are myocardial in nature. Thus, Wt1
mRNA and Wt1 protein expression are not restricted to the
(pro)epicardium in the developing heart; they are also found
in differentiated endothelial cells. A weak myocardial expres-
sion at E9.5 cannot be excluded at this point.
Wt1creEGFP Mediates Sporadic and Ectopic
Recombination in the Heart and the Rest of
the Embryo
Although endogenous expression of Wt1 in endothelial cells
of the developing heart does not allow a Wt1-based lineage
tracing system to claim an epicardial origin of this cell type,
fibroblasts, SMCs, and (possibly) cardiomyocytes still may
be analyzed for such a descent using this genetic tool.
However, this requires that the cre activity pattern recapitu-
lates endogenous expression of Wt1 in a faithful manner. To
stringently test if the Wt1creEGFP line that was previously used
for this approach fulfills this criterion,9 we performed a
careful analysis of the recombination activity of this line
Non-standard Abbreviations and Acronyms
E embryonic day
GFP green fluorescent protein
SMC smooth muscle cell
Tbx18 T-box gene 18
Wt1 Wilms tumor 1
Figure 1. Expression of Wt1 in cardiac development. A and
B, In situ hybridization analysis of Wt1 mRNA. C and D, Immu-
nofluorescence of Wt1 protein. E–G, Coimmunofluorescence of
Wt1 and the endothelial marker isolectin B4 (IB4) on heart sec-
tions of wild-type mouse embryos at embryonic day (E) 9.5 and
E14.5, as indicated. Arrows point to the epicardium. Arrow-
heads mark Wt1!IB4! cells in the endocardium and vessels.
Open triangles point to Wt1!IB4" cells in the myocardium.
Small arrows point to Wt1! cells in the interventricular septum.
Nuclei are counterstained with 4#,6-diamidino-2-phenylindol. a,
atrium; avc, atrioventricular canal; endo, endocardium; ivs, inter-
ventricular septum; myo, myocardium; lv, left ventricle; rv, right
ventricle; pe, proepicardium.
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during cardiogenesis using the Rosa26mTmG mouse line as a
sensitive reporter. In this reporter line, recombination is
easily visualized by bright membrane-bound green fluores-
cent protein (GFP) expression replacing a membrane-bound
red fluorescent protein, and anti-GFP immunofluorescence
analysis on sections additionally allows reliable cellular
resolution of cre recombination events.15
To our surprise, Wt1creEGFP/!Rosa26mTmG/! embryos ex-
hibited highly variable patterns of green fluorescence in the
entire embryo at E8.5 when neither Wt1 mRNA nor Wt1
protein was detected (Figure 2A–C, Online Figure I). GFP
expression analysis on embryo sections confirmed the sto-
chastic presence and random distribution of GFP-positive
cells in the heart at this stage. Recombination occurred in
cardiomyocytes and endocardial cells, as shown by coexpres-
sion with the myocardial marker Nkx2.5 and the endothelial
marker isolectin B4, respectively (Figure 2D–F, Online Fig-
ure II). At E9.5, GFP expression did not match endogenous
Wt1 expression but was again highly variable in all embry-
onic tissues (Online Figures I and III). GFP-positive cardio-
myocytes and endocardial cells were randomly distributed
throughout the heart and also were found in regions where the
epicardium had not yet settled (Online Figure III). Analysis
of E12.5 and E18.5 embryos revealed a similar variability of
GFP expression in all embryonic tissues; variable numbers of
cardiomyocytes and endothelial cells were positive for GFP
in the heart. At E18.5, we detected additional recombination
in the heart in a fraction of periostin-expressing fibroblasts
and Acta2-expressing SMCs (Online Figures IV and V). We
conclude that Wt1creEGFP-mediated reporter activity does not
reflect endogenous expression of Wt1, but occurs randomly
and sporadically in all embryonic tissues including the
myocardium, endocardium, and vessels of the heart.
Wt1creERT2 Recombines Inefficiently in the
Epicardium and Its Cellular Derivatives
Wt1creERT2 represents a second Wt1 allele that was used for
epicardial fate mapping as well as for “epicardium”-specific
gene deletion experiments.10,20,21 This allele mediates expres-
sion of a fusion protein of cre with a variant of the estrogen
receptor that allows activation of cre activity by administra-
tion of tamoxifen in a temporally controlled fashion.9 Our
initial tests revealed that injection of high doses of tamoxifen
before E11.5 results in embryonic lethality. Injection of 4 mg
of tamoxifen intraperitoneally to pregnant dams at E11.5 led
to earliest and highest recombination in our experience,
although this procedure resulted in premature delivery at
E16.5.
Analysis of GFP expression in Wt1creERT2/!Rosa26mTmG/!
hearts at E16.5 revealed low and highly variable levels of
recombination in the heart. Epicardial recombination was
incomplete, and limited GFP expression was detectable
throughout the ventricular compact myocardium and the
interventricular septum (Figure 3A–C). Double immunofluo-
rescence analysis for GFP and MF20 failed to detect recom-
bination within cardiomyocytes, whereas cells double-
positive for GFP and isolectin B4 (endothelial cells) and GFP
and Acta2 (SMCs) revealed rare recombination events in both
cell types (Figure 3D–F). Thus, the Wt1creERT2 line is inade-
quate to follow the cellular descendents of the (pro)epicardial
entity. The lack of recombination in cardiomyocytes indicates
that these cells are not epicardium-derived or, alternatively,
that Wt1-expressing cardiomyocytes are not present after
Figure 2. Wt1creEGFP-mediated recombination in embryonic
day (E) 8.5 embryos. Analysis of the recombination activity in
Wt1creEGFP/!Rosa26mTmG/! embryos and Rosa26mTmG/! control
mice at E8.5. A–C, Epifluorescence analysis of green fluorescent
protein (GFP) and red fluorescence protein (RFP) expression in
whole embryos. D–F, Immunofluorescence analysis of GFP, the
myocardial marker Nkx2.5, and the endothelial marker isolectin
B4 (IB4) on heart sections of a Wt1creEGFP/!Rosa26mTmG/!
embryo as indicated. Nuclei are counterstained with 4",6-
diamidino-2-phenylindol. hf, head folds; v, ventricle.
Figure 3. Inducible Wt1creERT2-mediated recombination in
late cardiac development. Pregnant mothers were injected
at embryonic day (E) 11.5 with tamoxifen and hearts of
Wt1creERT2/! Rosa26mTmG/! and Rosa26mTmG/! control mice an-
alyzed for recombination activity at E16.5. A–C, Immunofluores-
cence of GFP expression in sections of whole hearts. D–F,
Coimmunofluorescence of GFP, the myocardial marker MF20,
the endothelial marker isolectin B4 (IB4) and the smooth muscle
cell (SMC) marker Acta2 on sections of whole hearts. Shown are
higher magnification images of a region in the right ventricle (B).
Arrows point to the epicardium. Nuclei are counterstained with
4",6-diamidino-2-phenylindol. la, left atrium; lv, left ventricle; ra,
right atrium; rv, right ventricle.
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E10.5, even though the low recombination efficiency may
conceal some rare events.
Discussion
Our results show that Wt1 expression in the heart is not
restricted to the epicardium and that available Wt1cre
knock-in lines do not faithfully recapitulate endogenous
expression of Wt1 (Wt1creEGFP) and recombine poorly
(Wt1creERT2), respectively.
Expression analyses of Wt1 on the level of mRNA and
protein reported on subepicardial expression of the gene/
protein in addition to strong (pro)epicardial expression during
cardiac development. It was suggested that expression occurs
in epicardium-derived cells and, hence, that epicardial cells
maintain Wt1 expression after they have left the epicardial
continuity and become mesenchymal.16–18 Our expression
studies do not support this notion but strongly argue that
subepicardial expression of Wt1/Wt1 is mainly found in
endothelial cells of the endocardium and the coronary vascu-
lature. Expression levels in endothelial cells are lower than in
the epicardium but are likely to comprise the majority of
coronary vessels that form as a plexus that grows from the
sinus venosus toward the apex of the heart from E11.5 to
E14.5. Notably, Wt1 expression is reactivated in endothelial
cells of the coronary vasculature after myocardial infarc-
tion,22 indicating a conserved regulatory module for endothe-
lial Wt1 expression in development and regeneration. We
detected weak expression of Wt1 protein but not Wt1 mRNA
in the E9.5 myocardium. Alternative assays to in situ hybrid-
ization may address in the future whether low levels of Wt1
transcription actually occur in cardiomyocytes at this stage.
Endogenous expression of Wt1 in the endothelium/endocar-
dium, and possibly the myocardium in the developing heart
clearly excludes Wt1-based cre lines to trace an epicardial
contribution to myocardial, endothelial, and endothelium
derived cells in the mouse heart. Nonepicardial expression of
Wt1 also was reported in the zebrafish heart, which prompted
those investigators to exclude this gene from epicardial fate
mapping efforts in this species.23
Based on the strong epicardial expression of Wt1, two cre
lines have been developed to trace and manipulate epicardial
cells and their descendants. Our present study clearly has
shown that the Wt1creEGFP line mediates sporadic and highly
variable recombination in the heart as well as in the rest of the
embryo at stages when a (pro)epicardium is not present in the
embryo, and in a pattern that is incompatible with endoge-
nous Wt1 expression. The underlying reason for this random
activation of cre activity in this line remains unclear. We have
excluded the presence of a neo cassette, which might interfere
with proper transcriptional activation of cre. At present, we
assume that integration of the targeting vector was imprecise
or incorrect placing cre under different regulatory elements.
In contrast, recombination efficiency obtained with the
tamoxifen-inducible Wt1creERT2 line in epicardial cells was
extremely low, allowing for following the fate of a small set
of epicardium-derived cells only. Furthermore, epicardial fate
analysis was restricted to stages E11.5 onward because
injection of tamoxifen at earlier stages resulted in embryonic
death, as reported in other studies.24,25
We conclude that an epicardial origin of myocardial and
endothelial cells in the heart cannot be deduced using
Wt1-based cre/loxP technology. Our data additionally call for
cautious interpretation and reinvestigation of data obtained by
conditional gene deletion experiments using Wt1-based cre
lines.
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Novelty and Significance
What Is Known?
● The embryonic epicardium is a source of trophic signals that affects
the myocardium. It also is a source of cells that form the coronary
vasculature and the fibrous skeleton of the heart.
● During cardiac development, Wt1 is expressed in the proepicardium
and epicardium.
● Genetic lineage tracings based on Wt1 regulatory sequences have
provided suggestive evidence that epicardium-derived cells also
adopt a myocardial fate in the mouse.
What New Information Does This Article Contribute?
● Wt1 expression is not restricted to epicardial cells. During cardiac
development, the protein also is expressed in endothelial and
endocardial cells and, weakly, in cardiomyocytes.
● The Wt1creEGFP line mediates sporadic and highly variable recombi-
nation in all cardiac cell types, including cardiomyocytes, as well
as ectopic recombination at extracardiac sites.
● Wt1creERT2-mediated recombination in the epicardium is incomplete
and highly variable but does not occur in late cardiomyocytes.
The epicardium is an epithelial monolayer that covers and
mechanically protects cardiac muscle. During embryogenesis,
the epicardium also acts as a signaling center that promotes
myocardial growth and coronary plexus formation, and is a
source of cells for the fibrous skeleton of the heart, smooth
muscle cells, and fibroblasts of coronary vessels. Although these
functions have been confirmed for all vertebrates, a genetic
(cre/loxP-mediated) lineage tracing study based on regulatory
elements of the epicardially expressed Wt1 gene have sug-
gested that in the mouse, epicardial cells also substantially
contribute to the myocardium. This finding is of high clinical
relevance because it may open new avenues for deriving
cardiomyocytes for myocardial cell therapy. Our study shows
that Wt1 expression not only is restricted to the epicardium but
also is expressed in differentiated cells types of the heart,
namely endothelial cells and cardiomyocytes. Also, we provide
evidence that the Wt1creEGFP line that was used for epicardial
fate mapping before mediates ectopic and sporadic recombina-
tion in cardiomyocytes as well as in other cell types in which
Wt1 is not expressed. In addition, the inducible Wt1creERT2 line
recombines poorly in the epicardium, making it difficult to follow
all the descendants of this tissue. Thus, cardiomyocyte fate of
epicardial cells could not be substantiated using this approach.
Rudat and Kispert t1 and Epicardi l Fate Mapping 169
 at BIBLIOTHEK DER MEDIZINISCHEN on July 6, 2012http://circres.ahajournals.org/Downloaded from 
Part 3   
 Wt1 and epicardial fate mapping 
 
58 
 1 
Supplemental Online Data 
 
 
Wt1 and epicardial fate mapping 
 
 
 
Carsten Rudat and Andreas Kispert* 
 
 
 
Institut für Molekularbiologie, OE5250, Medizinische Hochschule Hannover, Carl-Neuberg-
Str.1, D-30625 Hannover, Germany 
 
 
*Author for correspondence:  
 E-MAIL: kispert.andreas@mh-hannover.de 
 TEL.:  +49 511 5324017 
 FAX.:  +49 511 5324283 
 
 
 
 
Part 3   
 Wt1 and epicardial fate mapping 
   59 
 2 
Supplemental Online Methods 
 
 
Mice and genotyping 
Mice with a knock-in of the cre recombinase gene in the Wt1 locus (Wt1tm1(EGFP/cre)Wtp, 
synonym: Wt1creEGFP)1, mice with a knock-in of the tamoxifen inducible cre-recombinase in 
the Wt1 locus (Wt1tm2(cre/ERT2)Wtp, synonym: Wt1creERT2)1 and the double fluorescent cre 
reporter line (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J, synonym: Rosa26mTmG)2 were obtained 
from the Jackson Lab and maintained on an outbred (NMRI) background. The fate of 
epicardial cells was analyzed in Wt1creEGFP/+;Rosa26mTmG/+ and Wt1creERT2/+;Rosa26mTmG/+ 
embryos. These were obtained from matings of Wt1creEGFP/+ and Wt1creERT2/+ males, 
respectively, with Rosa26mTmG/mTmG females. In the latter case, Tamoxifen (Sigma) was 
dissolved in ethanol at 100 mg/ml and then emulsified in corn oil (Sigma) to a final 
concentration of 12.5 mg/ml. 4 mg of Tamoxifen were intraperitoneally injected into mice at 
gestation day 11.5. Embryos for Wt1 expression analysis were obtained from matings of 
NMRI wildtype mice.  
For timed matings, vaginal plugs were checked in the morning after mating and noon was 
designated as embryonic day (E) 0.5. Female mice were sacrified by cervical dislocation. 
Embryos were harvested in PBS, decapitated, fixed in 4% paraformaldehyde overnight and 
stored in 100% methanol at -20oC before further use. Genomic DNA prepared from yolk sacs 
or tail biopsies was used for genotyping by PCR (protocols are available upon request). H. 
Hedrich, state head of the animal facility, approved the care of animals and experiments at 
Medizinische Hochschule Hannover.  
 
In situ hybridization analysis  
In situ hybridization analysis of 10-!m paraffine sections with digoxigenin-labeled antisense 
riboprobes followed published protocols.3  Details of used probes are available upon request. 
 
Immunohistochemistry  
For immunohistochemistry on 4-!m paraffine sections rabbit polyclonal antibody against Wt1 
(1:100, CA1026, Calbiochem), rabbit polyclonal antibody against GFP (1:200, sc-8334, 
Santa Cruz), mouse monoclonal antibody against GFP (1:200, #814460001, Roche), mouse 
monoclonal antibody against Acta2 (1:200, C6198, Sigma), mouse monoclonal antibody 
against Acta2 (1:200, F3777, Sigma), Fluorescein-labeled GSL I – isolectin B4 (1:100, FL-
1101, VectorLabs), mouse monoclonal antibody against MF 20 (1:200, Hybridoma Bank 
University of Iowa), rabbit polyclonal antibody against Nkx2.5 (1:200, ab35842, Abcam), 
rabbit polyclonal against Periostin (1:200, ab14041, Abcam) were used as primary 
antibodies.  
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Biotinylated goat-anti-rabbit (Dianova), Alexa488 goat-anti-rabbit (Invitrogen), Alexa488 
donkey-anti-mouse (Invitrogen A21202), biotinylated goat-anti-mouse (Dianova 115-067-
003), Alexa-Fluor555 goat-anti-mouse (Invitrogen A-21424) and Alexa-Fluor555 goat-anti-
rabbit (Invitrogen A-21428) were used in a dilution of 1:400 as secondary antibodies. Nuclei 
were stained with 4',6-diamidino-2-phenylindol (DAPI) (Roth). 
For antigen retrieval all sections were boiled for 3 min in antigen unmasking solution 
(H-3300, Vector Laboratories Inc) in a pressure cooker. Signal amplification was performed 
using the Tyramide Signal Amplification (TSA) system from Perkin-Elmer (NEL702001KT, 
Perkin Elmer LAS). For simultaneous detection of GFP and differentiation markers primary 
and secondary antibodies, respectively, were applied at the same time. 
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Supplemental Online Figures 
 
 
 
 
Online Figure I. Comparative analysis of endogenous expression of Wt1 mRNA and 
Wt1 protein and Wt1creEGFP mediated recombination in E8.5 and E9.5 embryos. A and D, 
in situ hybridization analysis of Wt1 mRNA; B and C, E and F, immunofluorescence analysis 
of Wt1 (in red, B and E) and GFP protein expression (in green, C and F) on sagittal sections 
of Wt1creEGFP/+;Rosa26mTmG/+ and Rosa26mTmG/+ control embryos at E8.5 and E9.5 as 
indicated. At E8.5, neither Wt1 mRNA nor Wt1 protein is detected whereas sporadic GFP 
expression is found throughout the embryo. At E9.5, Wt1 mRNA and Wt1 protein is found in 
the proepicardium, the forming epicardium (arrow in D and E) and the urogenital ridge 
(arrowhead in E). The GFP expression is highly variable throughout the heart and the whole 
embryo. a, atrium; hd, head; hf, head folds; lv, left ventricle; pe, proepicardium; s, somite; v, 
primitive ventricle. 
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Online Figure II. Wt1creEGFP-mediated recombination in E8.5 embryos. Analysis of the 
recombination activity in Wt1creEGFP/+;Rosa26mTmG/+ embryos and Rosa26mTmG/+ control mice at 
E8.5. A and B, immunofluorescence analysis of GFP expression on heart sections. C 
through F, coimmunofluorescence analysis of expression of the lineage marker GFP, the 
myocardial marker Nkx2.5, and the endothelial marker IB4 on heart sections, magnified 
regions are indicated by white rectangles.  Nuclei are counter-stained with 4',6-diamidino-2-
phenylindol. v, ventricle. 
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Online Figure III. Wt1creEGFP-mediated recombination in E9.5 embryos. Analysis of the 
recombination activity in Wt1creEGFP/+;Rosa26mTmG/+ embryos and Rosa26mTmG/+ control mice at 
E9.5. A through C, epifluorescence analysis of GFP and RFP expression in whole embryos. 
D through L, (co-) immunofluorescence analysis of GFP, the myocardial marker Nkx2.5, and 
the endothelial marker IB4 on heart sections as indicated. Magnified regions are indicated by 
white rectangles. Arrows point to the epicardium. Arrowheads mark GFP+IB4+ cells in the 
endocardium. Open triangles point to GFP+IB4- cells in the myocardium. Nuclei are counter-
stained with 4',6-diamidino-2-phenylindol. a, atrium; lv, left ventricle; pe, proepicardium. 
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Online Figure IV. Wt1creEGFP mediated recombination in E12.5 hearts. Analysis of the cre 
recombination activity by GFP expression in E12.5 hearts of Wt1creEGFP;Rosa26mTmG/+ and 
Rosa26
mTmG/+ control embryos. A through F, (Co-)immunofluorescence analysis of GFP (in 
green, membranes) and the myocardial marker Nkx2.5 (in red, nuclei) on transverse heart 
sections as indicated. D through F show higher magnification images of the right ventricle. 
White arrows point to the epicardium. la, left atrium; lv, left ventricle; ra, right atrium; rv, right 
ventricle. 
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Online Figure V. Wt1creEGFP-mediated recombination in E18.5 embryos and hearts. 
Analysis of cre recombination activity in Wt1creEGFP;Rosa26mTmG/+ embryos and Rosa26mTmG/+ 
control mice. A through F, epifluorescence analysis of GFP and RFP expression in 
embryonic trunks (A through C) and hearts (D through F). G through U, 
(co-)immunofluorescence analysis of GFP (in green, membranes) and the myocardial marker 
MF20, the endothelial marker IB4, the SMC marker Acta2, and the fibroblast marker Postn 
(all in red) on sections of whole hearts as indicated. J through U show higher magnification 
images of the right ventricle. fl, fore limb; hl, hind limb; la, left atrium; lv, left ventricle; ra, right 
atrium; rv, right ventricle. 
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Abstract 
 
Rationale: The embryonic epicardium is a crucial source of cells for the cardiac fibrous 
skeleton and the coronary vasculature. Previous reports suggested that Wnt-, Hh-, 
Fgfr1/Fgfr2- and Pdgfrα-signaling pathways are required in the epicardium for mobilization 
and differentiation of epicardial cells, and/or for the formation of the coronary vasculature. 
However, the cre lines used for conditional ablation of these pathways might not have been 
specific for the epicardium. 
Objective: To determine the relevance of canonical Wnt-, Hh-, Fgfr1/Fgfr2- and Pdgfrα-
signaling in the developing epicardium.  
Methods and Results: We used a Tbx18cre-mediated conditional approach to delete and to 
stabilize, respectively, the unique downstream mediator of canonical Wnt-signaling, Ctnnb1, 
to delete and to stabilize, respectively, the unique downstream mediator of Hh-signaling, 
Smo, and to delete Fgfr1/Fgfr2 and Pdgfrα in epicardial development. We show that 
epicardial loss of Ctnnb1 does not affect cardiac development whereas epicardial expression 
of a stabilized version of Ctnnb1 results in formation of hyperproliferative epicardial cell 
clusters. Epicardial loss of Shh and Smo does not affect cardiac development whereas 
expression of a constitutively active version of Smo in the epicardium leads to epicardial 
thickening and loss of epicardial mobilization. Epicardial loss of Fgfr1 and Fgfr2 does not 
affect cardiac development either. In contrast, epicardial loss of Pdgfrα prevents 
differentiation of epicardium-derived cells into mature fibroblasts. 
Conclusions: Our data question earlier reports on a role of canonical Wnt-, Hh- and 
Fgfr1/Fgfr2-signaling in epicardial development. They support the notion that Pdgfrα-
signaling is crucial for differentiation of cardiac fibroblasts from epicardium-derived cells.  
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Non-standard abbreviations and acronyms 
 
DAPI  4,6-diamidino-2-phenylindole 
E  embryonic day 
EMT   epithelial-mesenchymal transition 
EPDC  epicardium-derived cell 
SM   smooth muscle 
SMC  smooth muscle cell 
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Introduction 
 
The epicardium, the outer epithelial lining of the heart, exerts a crucial role both during 
development and disease as a source of signals and cells for the underling myocardium and 
the coronary vasculature. The epicardium arises from extracardiac precursor cells that 
constitute a grape-like aggregate at the venous pole of the developing heart. Groups of cells 
detach from this proepicardium, and adhere on the overlying myocardium from around 
embryonic day (E) 9.5 in the mouse. At E10.5, these cell clusters have spread out and 
formed a contiguous epithelial monolayer. Concomitant with the ingrowth of the coronary 
endothelium from the sinus venosus at E12.5, individual epicardial cells undergo an 
epithelial-mesenchymal transition (EMT) and migrate into the subepicardial space. These 
epicardium-derived cells (EPDCs) differentiate into interstitial and perivascular fibroblasts 
and into smooth muscle cells (SMCs) that surround the coronary vessels.1,2 A contribution to 
coronary endothelia and cardiomyocytes has been reported in some lineage tracing studies 
in the mouse but was not confirmed in other studies or found in other vertebrates.3,4,5,6,7,8,9 
Intriguingly, in myocardial injury conditions the adult epicardium reactivates an embryonic 
gene program and supports myocardial healing (in zebrafish) and revascularization and scar 
formation (in the mouse) by secretion of angiogenetic factors and differentiation of 
fibroblasts.10,11 
Mobilization and differentiation of epicardial cells is likely to be controlled by a number of 
autocrine and paracrine signals as suggested by the phenotypic consequences of mice with 
epicardium-specific (cre/loxP-mediated) deletion of crucial signaling components.2,12 Using 
cre lines based on GATA binding protein 5 (Gata5)- and Wilms tumor 1 homolog (Wt1)-
regulatory elements and a floxed allele of beta-catenin (Ctnnb1), a functional requirement of 
the canonical (Ctnnb1-dependent) wingless-related MMTV integration site (Wnt)-signaling 
pathway in epicardial EMT and coronary SMC differentiation was suggested.13,14 Loss of 
platelet-derived growth factor receptor alpha (Pdgfrα) resulted in reduced EMT and a deficit 
in cardiac fibroblast formation,15 which holds true as well for the combined conditional loss of 
fibroblast growth factor (Fgf) receptors 1/2 which was similarly achieved by a Wt1cre-
mediated recombination of floxed alleles in the epicardium.16 Furthermore, epicardial derived 
Fgf-signals have been shown to induce sonic hedgehog (Shh) signaling, which in turn, 
regulates the formation of arterial and venous coronaries.17 Finally, we showed by T-box18 
(Tbx18)cre-mediated epicardial deletion of the gene encoding the transcription factor 
recombination signal binding protein for immunoglobulin kappa J region (Rbpj) that Notch-
signaling regulates SMC differentiation of EPDCs once they have reached a perivascular 
position.6 Shared phenotypic consequences may argue for pathway cooperation in distinct 
epicardial subprograms including EMT (Wnt/Pdgfrα/Fgfr1,2) and SMC differentiation 
(Wnt/Notch). However, recent studies indicated that the Gata5::cre line and the Wt1cre 
lines,18,4 that were used in these conditional gene targeting experiments, may not have been 
specific for the epicardium but mediated wide-spread recombination in other cardiac cell 
types as well.19,20 Before embarking on genetic interaction studies of Notch-signaling with 
any of these pathways, we therefore wished to reevaluate the epicardial requirement of these 
pathways (canonical Wnt, Fgfr1/Fgfr2, Hh, Pdgfrα) using the Tbx18cre line which we have 
recently characterized to mediate specific recombination in the epicardium of the right 
ventricle.6  
Here, we show that in mice with epicardial (Tbx18cre-mediated) deletion of Ctnnb1, Fgfr1/2, 
Shh and of the gene encoding the Shh signal transducer smoothened (Smo) epicardial 
mobilization and differentiation is undisturbed. Using genetic gain-of-function approaches, we 
find evidence that epicardial activation of canonical Wnt- and Hh-signaling is actually 
deleterious for epicardial and myocardial development in vivo. Furthermore, we confirm that 
Pdgfrα is required for epicardial EMT and differentiation of cardiac fibroblasts. 
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Material and Methods 
 
Mice 
Mice with a knock-in of the cre-recombinase gene in the Tbx18 locus (Tbx18tm4(cre)Akis, 
synonym: Tbx18cre) were previously generated in the laboratory at the Medizinische 
Hochschule Hannover.21 Mice with loxP sites flanking the Ctnnb1 locus from exon 2 to exon 
6 (Ctnnb1tm2Kem synonym: Ctnnb1fl) were obtained from Rolf Kemler (Max-Planck-Institute for 
Immunobiology and Epigenetics, Freiburg/Germany),22 mice with loxP sites flanking exon 3 
of the Ctnnb1 locus (Ctnnb1tm1Mmt, synonym: Ctnnb1(Ex3)fl) were obtained from 
Makoto Mark Taketo (Kyoto University, Kyoto/Japan).23 Mice with loxP sites flanking exon 2 
of the Shh locus (Shhtm2Amc, synonym: Shhfl),24 mice with loxP sites flanking exon 4 of the 
Fgfr1 locus (Fgfr1tm5.1Sor, synonym: Fgfr1fl),25 mice with loxP sites flanking exons 7 to 10 of 
the Fgfr2 locus (Fgfr2tm1Dor, synonym: Fgfr2fl),26 mice with loxP sites flanking exon 1 of the 
Smo locus (Smotm2Amc, synonym: Smofl),27 mice with a fusion protein of Enhanced Yellow 
Fluorescent Protein (EYFP) and the constitutively active W539L point mutation of the Smo 
protein and a loxP-flanked STOP fragment placed between its Gt(ROSA)26Sor promotor and 
the Smo/EYFP sequence (Gt(ROSA)26Sortm1(Smo/YFP)Amc, synonym: SmoGOF),28 mice with loxP 
sites flanking exons 1 to 4 of the Pdgfrα locus (Pdgfrαtm8Sor, synonym: Pdgfrαfl),29 and the 
double fluorescent cre reporter line (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo, synonym: 
R26mTmG)30 were all obtained from the Jackson Laboratory (Bar Harbor, Maine, USA). All 
mice were maintained on an outbred (NMRI) background. 
An expanded Materials and Methods section is available in the online data supplement. 
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Results 
 
Tbx18cre allows epicardium-specific recombination of loxP-flanked sequences  
The T-box transcription factor gene Tbx18 is strongly expressed in the proepicardium at E9.5 
and in the epicardium until E16.5. Other cardiac expression domains include the sinus 
venosus, and the myocardium of the left ventricle and the interventricular septum.31,6 Using 
Rosa26mTmG reporter mice we recently demonstrated that cre expression from the Tbx18 
locus mediates recombination in all known Tbx18 expression domains and their cellular 
descendants in the heart from E9.5 to E14.5 in a faithful manner. In the right ventricle, 
EPDCs were shown to differentiate into interstitial and perivascular fibroblasts and coronary 
SMCs but not into endothelial cells and cardiomyocytes.6 Since a recent analysis suggested 
that Tbx18 expression is restricted to a subset of proepicardial cells, and might therefore not 
mark all epicardial cells and their descendants,8 we reevaluated epicardial expression of 
Tbx18 at E10.5 when a contiguous epicardial layer is formed but EMT has not yet 
commenced. Immunofluorescence analysis of Tbx18 and DAPI nuclear counterstain showed 
that at this stage all epicardial cells (delineated by collagen (Col)4 staining) expressed 
Tbx18. Furthermore, Tbx18cre mediated expression of membrane-bound GFP from the 
Rosa26mTmG reporter in all epicardial cells at E10.5, confirming our previous results that 
Tbx18cre represents a suitable tool for analysis of epicardial gene function (Online Figure I). 
 
 
 
Canonical Wnt-signaling is dispensable for epicardial development 
To analyze canonical Wnt-signaling in epicardial development, we investigated the 
expression of Axin2, a bona fide transcriptional target of this pathway,32 by in situ 
hybridization on sections of E9.5 to E14.5 embryonic hearts (Online Figure II). Expression of 
Axin2 was neither detected in the E9.5 proepicardium nor in the epicardium at subsequent 
stages although other sites of Axin2 expression were readily identified. Since this assay 
cannot unambiguously exclude low levels of canonical Wnt-signaling in epicardial cells, we 
used our Tbx18cre line and a floxed allele of Ctnnb1 (Ctnnb1fl),22 the unique intracellular 
mediator of the canonical sub-branch of Wnt-signaling, to test for a functional requirement of 
this pathway in epicardial development. Immunofluorescence analysis on sections of hearts 
of E9.5 and E14.5 Tbx18cre/+;Ctnnb1fl/fl;Rosa26mTmG/+ embryos revealed absence of Ctnnb1 
from the proepicardium and epicardium but not from the myocardium confirming the 
suitability of the approach to specifically delete Ctnnb1, thus, canonical Wnt-signaling in all 
epicardial cells (Online Figure III). 
Tbx18cre/+;Ctnnb1fl/fl;Rosa26mTmG/+ mice survived embryogenesis but died due to skeletal 
malformations shortly after birth. On histological sections mutant ventricles seemed 
unaffected at E18.5; the ventricular wall thickness was normal and the integrity of the septa, 
valves and the epicardium was preserved (Figure 1). Since epicardial cells and signals direct 
the outgrowth of the coronary plexus, and the formation of coronary SMCs and the fibrous 
skeleton, we analyzed by immunofuorescence of marker proteins on transverse sections of 
E18.5 hearts for the presence and distribution of endothelial cells (isolectin-B4 staining 
(IB4)), of SMCs (transgelin (Tagln, also known as Sm22)) and of fibroblasts (periostin 
(Postn)). Stainings for all three markers and the capillary density in the right ventricle was 
indistinguishable between mutant and wildtype hearts, indicating that the coronary 
vasculature and the fibrous skeleton were not affected by epicardial deletion of Ctnnb1. 
Finally, immunofluorescent detection and subsequent quantification of the lineage reporter 
GFP from the Rosa26mTmG allele visualized normal generation and distribution of epicardial 
cells and their descendants in mutant hearts both at E13.5 and E18.5 (Figure 1 and Online 
Figure IV). 
To further investigate the character of Ctnnb1-deficient epicardial cells, we generated 
primary epicardial cell cultures from explants of right ventricles of E11.5 hearts. After four 
days in serum-free medium wildtype cells presented as a monolayer of tightly packed 
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hexagonal cells that showed membrane staining of the epithelial markers Ctnnb1 and tight 
junction protein 1 (Tjp1, also known as ZO1), nuclear staining of the epicardial marker Wt1 
and weak cortical staining of the SM marker actin, alpha 2, smooth muscle, aorta (Acta2). In 
Ctnnb1-deficient cells Ctnnb1 was absent but the patterns of Tjp1, Wt1 and Acta2 expression 
were normal confirming their character as epicardial precursor cells (Online Figure VA). 
Irrespective of the genotype, addition of 10% FCS to the medium resulted in loss of Tjp1 and 
Wt1, and formation of Acta2-positive stress fibres, consistent with EMT and differentiation 
into SMCs (Online Figure VB). These results demonstrate that the epicardial loss of Ctnnb1 
does not affect the formation of the epicardium, EMT or differentiation of EPDCs in vitro and 
in vivo.  
 
 
 
Figure 1. Epicardial loss of Ctnnb1 does not lead to defects in the coronary 
vasculature, the ventricular myocardium or in epicardial derivatives. Histological 
analysis by hematoxylin and eosin staining (H&E) and immunofluorescence analysis of IB4, 
Tagln, Postn and the cell-lineage marker GFP on mid-transverse sections of E18.5 
Tbx18cre;Rosa26mTmG/+;Ctnnb1fl/+ (control) and Tbx18cre;Rosa26mTmG/+;Ctnnb1fl/fl (mutant) 
hearts. Insets show higher magnification images of the areas marked with rectangles. lv, left 
ventricle; rv, right ventricle. 
 
 
Epicardial expression of a stabilized version of Ctnnb1 leads to formation of epicardial 
cell clusters  
To further clarify the role of Ctnnb1-dependent Wnt-signaling in epicardial development, we 
used a gain-of-function approach with conditional (Tbx18cre-mediated) overexpression of a 
stabilized form of Ctnnb1 (Ctnnb1(Ex3)fl).23 Tbx18cre/+;Ctnnb1(Ex3)fl/+ embryos died at E12.5 
probably due to cardiovascular insufficiency as shown by formation of edema. Morphological 
examination of whole hearts at E11.5 using GFP epifluorescence revealed a reduced overall 
size, ballooned atria and clusters of fluorescent cells on the ventricular surface (Figure 2A). 
Histological inspection exposed a severely thinned ventricular myocardium, as well as 
defined subepicardial cell clusters (Figure 2B).  
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Figure 2. Epicardial expression of a stabilized version of Ctnnb1 induces formation of 
large cell aggregates on the surface of E11.5 hearts. (A) GFP epifluorescence in whole 
hearts in a dorsal view, (B through H) analysis of mid-transverse heart sections by 
hematoxylin and eosin (H&E) staining (B), by immunofluorescence of GFP (C), by in situ 
hybridization analysis for expression of Axin2, Aldh1a2 and Tnni3 (D through F), and by 
immunofluorescence of Acta2 and Fn1 (G and H) of control (Tbx18cre;Rosa26mTmG/+) and 
mutant (Tbx18cre;Rosa26mTmG/+;Ctnnb1(Ex3)fl/+ embryos. Arrows point to the epicardium. avc, 
atrioventricular canal; cs, coronary sinus; la, left atrium; lv, left ventricle; ra, right atrium; rv, 
right ventricle. (I) Quantitative analysis of proliferation rates (% BrdU labeling index) of the 
epicardium and the cell clusters in genotypes as shown. Probability value is P=0.002. 
 
 
 
 
Analysis of individual clusters by immunofluorescence for GFP proved the epicardial origin of 
these clusters (Figure 2C), which expressed as expected high levels of Axin2 (Figure 2D), 
indicating active Ctnnb1-dependent Wnt-signaling. In situ hybridization analysis of the 
epicardial marker gene aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2) and the 
cardiomyocyte marker troponin I, cardiac 3 (Tnni3), and immunofluorescence for Acta2 
showed, that these cell clusters were neither epicardial nor myocardial in nature and did not 
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differentiate into SMCs. However, the clusters produced high levels of the extracellular matrix 
protein fibronectin (Fn)1 that is associated with fibroblast-like cells (Figure 2E-H). The BrdU 
proliferation assay uncovered a significantly (P=0.003) elevated proliferation rate at E11.5 
both within the epicardial layer (44±7%) and the Axin2+ cell clusters (47±6%) in the mutant 
compared to the control epicardium (22±5%) (Figure 2I and Online Figure VI). Thus, 
epicardium-specific expression of a stabilized form of Ctnnb1 results in hyperproliferation of 
epicardial cells and formation of cellular aggregates of fibroblast-like cells indicating that 
active canonical Wnt-signaling is deleterious for epicardial development. 
 
Epicardial Hh-signaling is dispensable  
To determine the presence of Hh-signaling in the developing epicardium, we investigated the 
expression of patched homolog1 (Ptch1), a well established transcriptional target and a 
repressor of Hh-signaling33 by in situ hybridization on sections of E9.5 to E14.5 embryonic 
hearts. Expression of Ptch1 was neither detected in the E9.5 proepicardium nor in the 
epicardium at subsequent stages although other sites of Ptch1 expression were clearly 
visible (Online Figure VII). To test for a functional requirement of this pathway in epicardial 
development, we used our Tbx18cre line and a floxed allele of smoothened (Smofl)27 which 
encodes a unique intracellular transducer of Hh-signaling. Tbx18cre/+;Smofl/fl;Rosa26mTmG/+ 
mice survived embryogenesis but died due to skeletal malformations shortly after birth. On 
histological sections mutant ventricles seemed unaffected at E18.5; the ventricular walls 
were of normal thickness, and valvuloseptal tissues and the epicardial lining were preserved 
in their integrity. Formation of IB4+ endothelial cells and of the endomucin (Emcn)+ venous 
and capillary network of the coronary vasculature34 was normal and Acta2+ SMCs 
surrounded the endothelial linings of the larger arteries as in the control situation. Postn was 
widely distributed throughout the ventricular walls of the mutant hearts indistinguishable from 
the control. Finally, the lineage reporter GFP from the Rosa26mTmG allele confirmed normal 
generation and distribution of epicardial cells and their descendants in mutant hearts both at 
E14.5 and E18.5 (Figure 3 and Online Figure VIII). 
 
 
 
Figure 3. Epicardial loss of Smo does not lead to defects in the coronary vasculature, 
the ventricular myocardium or in epicardial derivatives. Histological analysis by 
hematoxylin and eosin staining (H&E) and immunofluorescence analysis for IB4/Emcn, 
Tagln, Postn and the cell-lineage marker GFP on mid-transverse sections of E18.5 
Tbx18cre;Rosa26mTmG/+;Smofl/+ (control) and Tbx18cre;Rosa26mTmG/+;Smofl/fl hearts. Insets show 
higher magnification images of the areas marked with rectangles. lv, left ventricle; rv, right 
ventricle. 
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Epicardial expression of a constitutive active version of Smo disrupts cardiac 
development 
To investigate the consequences of epicardial activation of Hh-signaling, we (mis-)expressed 
a constitutively active form of Smo from the Rosa26 locus (SmoGOF)28 using a Tbx18cre-
mediated approach. Tbx18cre/+;Rosa26mTmG/+;SmoGOF/+ embryos died after E13.5 showing 
severe edema formation. Histological sections of E13.5 mutant embryos revealed a severely 
hypoplastic ventricular myocardium, a thinned compact myocardial layer and a thickened 
epicardium (Figure 4A and B). The early coronary plexus formed (shown by IB4 staining), 
even though the vessels were not located in the deeper compact myocardium (Figure 4C). 
Immunofluorescent detection of the lineage marker GFP and the epicardial marker Wt1 
showed an accumulation of epicardial cells and/or EPDCs and a severe reduction of EMT 
and immigration into the myocardium (Figure 4D through F). Surprisingly, epicardial 
proliferation, as detected by the BrdU incorporation assay, was significantly reduced, 
whereas myocardial proliferation was unaltered at E13.5 (Figure G and H). Thus, 
epicardium-specific expression of a constitutive active form of Smo results in an increase in 
epicardial cell density, lack of epicardial EMT and disturbed epicardial-myocardial signaling. 
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Figure 4. Expression of a constitutive active form of Smo affects epicardial and 
myocardial integrity in E13.5 hearts. (A through G) Mid-transverse sections of E13.5 
hearts of control (Tbx18cre;Rosa26mTmG/+) and mutant (Tbx18cre;Rosa26mTmG/+;SmoGOF/+) 
embryos were analyzed by hematoxylin and eosin (H&E) staining (A and B), by 
immunofluorescence analysis for IB4 (C), the lineage marker GFP (D and E), the epicardial 
marker Wt1 (F) and the proliferation marker BrdU (G). (A and D) show whole hearts, (B and 
C, E through G) magnified regions of the right ventricle. (H) Proliferation rates (% BrdU 
labeling index) of the epicardium in genotypes and stages as shown. Probability values 
epicardium, P=0.02; myocardium, P=0.6. la, left atrium; lv, left ventricle; ra, right atrium; rv, 
right ventricle. 
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Epicardial Shh is dispensable for heart development 
Although Hh-signaling within the epicardium is dispensable for normal heart development, 
epicardial Hh-signals may act onto the underlying myocardium and coronary system. In fact, 
it was previously suggested that epicardial Shh-signaling to cardiomyocytes and perivascular 
cells is required for the expression of vascular endothelial growth factors (VEGFs), thus, may 
promote growth of the vascular plexus.17 Our in situ hybridization analysis on sections of 
E9.5 to E14.5 embryonic hearts (Online Figure IX) did not detect expression of the genes 
encoding the three Hh-ligands (Shh, Dhh and Ihh) although expression at other sites was 
easily detected. Furthermore, embryos with epicardial (Tbx18cre-mediated) deletion of Shh24 
(Tbx18cre/+;Shhfl/fl;Rosa26mTmG/+) survived embryogenesis, and exhibited hearts that were 
histologically indistinguishable from the wildtype control. The coronary network (IB4), the SM 
lining of the coronary arteries (Tagln), the fibroskeleton (Postn) and the formation of EPDCs 
(GFP) were all unchanged (Figure 5 and Online Figure X). Thus, epicardial loss of Shh does 
not affect embryonic development of the heart. 
 
 
 
Figure 5. Epicardial loss of Shh does not lead to defects in the coronary vasculature, 
the ventricular myocardium or in epicardial derivatives. Histological analysis by 
hematoxylin and eosin staining (H&E) and immunofluorescence analysis of IB4, Tagln, Postn 
and the cell-lineage marker GFP on mid-transverse sections of E18.5 control 
(Tbx18cre;Rosa26mTmG/+;Shhfl/+) and mutant (Tbx18cre;Rosa26mTmG/+;Shhfl/fl) hearts. Insets 
show higher magnification images of the areas marked with rectangles. lv, left ventricle; ra, 
right atrium; rv, right ventricle. 
 
 
 
Epicardial Fgfr1/Fgfr2-signaling is not required for heart development 
Epicardial Fgfr1/Fgfr2-signaling was recently proposed to induce EPDC migration and 
fibroblast formation.16 However, our in situ hybridization analysis did not detect (pro-
)epicardial expression of Etv4, a bona fide transcriptional target of the Fgf signaling 
pathway,35 on sections of E9.5 to E14.5 embryonic hearts (Online Figure XI). Moreover, 
embryos with Tbx18cre-mediated epicardial deletion of Fgfr1 and Fgfr225,26 
(Tbx18cre/+;Fgfr1fl/fl;Fgfr2fl/fl) survived embryogenesis and presented histologically normal 
hearts.  
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Figure 6. Combined epicardial loss of Fgfr1 and Fgfr2 does not affect the integrity of 
the coronary vasculature, the ventricular myocardium or epicardial derivatives. 
Histological analysis by hematoxylin and eosin staining (HE) and immunofluorescence 
analysis for IB4, Tagln, Postn and the cell-lineage marker GFP on mid-transverse sections of 
E18.5 control (Tbx18cre/+;Fgfr1fl/+;Fgfr2fl/+;Rosa26mTmG/+) and mutant 
(Tbx18cre/+;Fgfr1fl/fl;Fgfr2fl/fl;Rosa26mTmG/+) hearts. Insets show higher magnification images of 
the areas marked with rectangles. lv, left ventricle; rv, right ventricle. 
 
The networks of coronary endothelial cells (IB4), SMCs (Tagln), fibroblasts (Postn) and 
EPDCs (GFP) were not altered either (Figure 6 and Online Figure XII) suggesting that 
Fgfr1/Fgfr2-signaling in the epicardium is not essential for the development of the epicardium 
and the coronary system. 
 
 
Epicardial Pdgfrα is important for cardiac fibroblast differentiation 
Finally, we analyzed the role of Pdgfrα-signaling29 in epicardial development by a conditional 
approach. Tbx18cre/+;Pdgfrαfl/fl;Rosa26mTmG/+ mice survived embryogenesis. Histological and 
immunofluorescence analysis did not reveal changes of the ventricular walls (H&E), of the 
coronary endothelial network (IB4) and of the distribution of SMCs around the arteries 
(Tagln) between mutant and control hearts at E18.5.  
 
 
Figure 7. Epicardial Pdgfrα is required for cardiac fibroblast differentiation. Histological 
analysis by hematoxylin and eosin staining (H&E) and immunofluorescence analysis for IB4, 
Tagln, Postn and the cell-lineage marker GFP on mid-transverse sections of E18.5 
Tbx18cre/+;Pdgfrαfl/+;Rosa26mTmG/+ (control) Tbx18cre/+;Pdgfrαfl/fl;Rosa26mTmG/+ hearts. Insets 
show higher magnification images of the areas marked with rectangles. lv, left ventricle; rv, 
right ventricle. 
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Discussion 
 
The embryonic epicardium is a crucial source of cells for the underlying myocardium and the 
coronary vasculature. Here, we have shown that mobilization and differentiation of epicardial 
cells does not depend on epicardial Wnt-, Fgfr1/2- and Shh/Smo-signaling but that 
differentiation of EPDCs into fibroblasts requires the Pdgfrα-signaling pathway. 
Discrepancies between our results and that of earlier reports may rely on the usage of 
different cre lines. 
 
Canonical Wnt-signaling is deleterious for epicardial development  
Canonical Wnt-signaling has been shown to regulate proliferation and differentiation of 
progenitor cells in various developmental contexts.36 In the developing heart a crucial role for 
this pathway was uncovered in the proliferation of myocardial progenitors of the right 
ventricle, the atria, the outflow tract and the cardiac venous pole.37 An additional requirement 
in epicardial mobilization and differentiation was suggested by a number of studies. First, 
active Wnt signaling was detected in the proepicardium and single cells of the epicardium 
using a transgenic Wnt reporter.38,39 Second, reduced EMT and a failure of coronary SMC 
differentiation was reported upon conditional deletion of Ctnnb1 using the transgenic 
Gata5::cre line.13 Third, Wt1cre-mediated deletion of Ctnnb1 resulted in a complete absence 
of epicardial EMT14. However, a recent study mentioned that these mice survive to 
adulthood,40 questioning the earlier conclusions. Our combined analysis on expression 
(using the faithful read-out by the Wnt-target gene Axin2), and Tbx18cre-mediated loss- and 
gain-of-function of Ctnnb1 does not only suggest that this pathway is irrelevant for epicardial 
EMT and SMC differentiation but that, in fact, an epicardial activity is deleterious for cardiac 
development. Since previous work showed that recombination by Gata5::cre is not restricted 
to epicardial cells but occurs in a widespread fashion in cardiomyocytes, cushion tissue and 
endothelial cells,19 and that the Wt1cre line mediates widespread recombination outside the 
epicardium in all cardiac and extracardiac tissues,20 we assume that previous results can be 
explained by non-specificity of the used cre lines but also to a lack of suitable tracing 
methods and histochemical assays.  
 
Hh-signaling is deleterious for epicardial development 
The Hh-signaling pathway has been shown to be important for vasculogenesis in adult and 
embryonic development.41 Claims for a specific role of the pathway in the epicardium and 
EPDCs were drawn from identification of Shh and Ptch1 expression in the epicardium and 
from a conditional (Dermo1cre-mediated) deletion of Smo that resulted in the reduction of 
coronary artery formation at the early coronary plexus stage.42,17,43 Our investigations on the 
expression of Hh-ligands (Shh, Ihh, Dhh) and the Hh-pathway target gene (Ptch1) on cardiac 
sections revealed no presence of these components in the developing epicardium indicating 
the possibility that previous expression results on whole hearts were artefacts. Further, our 
conditional loss- and gain-of-function mutants of the Hh-signaling pathway do not confirm a 
functional relevance for this pathway in the epicardium but indicates deleterious 
consequences upon cardiac development once epicardially activated. Since the previously 
used Dermo1cre line is additionally active in cushion tissue,44 these experiments may point to 
an endothelial/endocardial requirement of Hh-signaling that was erroneously investigated. 
Furthermore, analysis of embryos at stages of early (highly variable) coronary plexus 
outgrowth rather that around birth when the coronary system is well established and 
functional might have contributed in erroneously assigning an epicardial function to Hh-
signaling. 
 
Fgfr1/Fgfr2-signaling is not required for epicardial development 
Fgf-signals have been characterized as important paracrine regulators of proliferation, 
migration and differentiation of numerous cell types.45 A crucial function for epicardial 
mobilization was suggested by several studies. First, Fgf ligands were shown to stimulate 
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EMT in cultured avian epicardial cells.46 Second, pharmacological inhibition of Fgfr-signaling 
impaired epicardial EMT in avian proepicardial explants.47 Third, reduced EPDC migration 
and formation of interstitial fibroblasts was reported upon conditional deletion of Fgfr1 and 
Fgfr2 using the Wt1cre-line.16 Our analysis of expression of Etv4 does not support the notion 
that epicardial cells display active Fgf-signaling. Furthermore, combined (Tbx18cre-mediated) 
loss of Fgfr1 and Fgfr2 was without phenotypic consequences for epicardial and myocardial 
development. We suggest that haploinsufficiency of Wt1 might have interfered with formation 
and migration of EPDCs and has clearly reduced the sensitivity of Wt1 detection that was 
used as an EPDC marker in the previous study.12 Further, endothelial expression of Wt1 in 
the coronary plexus might have further negatively impacted on the characterization of 
EPDCs in those experiments.20  
 
Epicardial Pdgfrα is critical for cardiac fibroblast differentiation 
Pdgfs have been characterized as crucial signals in the proliferation of mesenchymal 
precursor cells, as well as their differentiation and migration.48 Reports on a functional 
involvement of Pdgfrα-signaling in epicardial development were based on the results from 
conditional deletion of Pdgfrα using the Wt1cre-line.15 Our conditional (Tbx18cre-mediated) 
deletion experiment confirms that Pdgfrα is required for epicardial EMT, and more critically 
for differentiation of EPDCs in mature cardiac fibroblasts. Congruency of the results in this 
case is easily explained by the fact that extraepicardial recombination mediated by Wt1cre in 
the heart is irrelevant for a gene the expression of which is restricted to the epicardium 
during cardiac development.  
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What is known? 
 
• The embryonic epicardium is a source of trophic signals for the myocardium and a cellular 
source for the coronary vasculature and the fibrous skeleton of the heart. 
• Conditional gene targeting approaches have provided suggestive evidence that canonical 
Wnt-, Fgfr1/Fgfr2- and Pdgfrα-signaling regulate epicardial mobilization, and 
differentiation into smooth muscle cells and cardiac fibroblasts. 
• Conditional gene targeting approaches have provided suggestive evidence that epicardial 
Hh-signaling regulates the formation of the coronary vasculature. 
 
 
What new information does this article contribute? 
 
• Canonical Wnt-signaling in the epicardium is not required epicardial development.  
• Epicardial activation of canonical Wnt-signaling disrupts epicardial and myocardial 
integrity. 
• Epicardial Hh-signaling is not required for the development for the epicardium and the 
coronary vasculature. 
• Epicardial activation of Hh-signaling affects epicardial EMT and myocardial growth. 
• Epicardial Fgfr1/Fgfr2-signaling is not required for epicardial development. 
• Epicardial Pdgfrα-signaling regulates epicardial EMT and differentiation of cardiac 
fibroblasts from epicardium-derived cells.  
 
 
Novelty and significance 
 
The epicardium is an epithelial monolayer that covers and mechanically protects the cardiac 
muscle. During embryogenesis and in myocardial injury, the epicardium also acts as a 
signaling center that promotes myocardial growth and coronary plexus formation, and is a 
source of cells for the fibrous skeleton of the heart as well as for smooth muscle cells and 
fibroblasts of coronary vessels. Reactivation of embryonic epicardial programs by 
manipulation of relevant signaling pathways may provide a means to increase myocardial 
healing under injury conditions. Conditional gene targeting approaches have implicated a 
number of intracellular signaling pathways to regulate epicardial mobilization and 
differentiation during embryogenesis. Canonical (Ctnnb1-dependent) Wnt-signaling was 
suggested to regulate epicardial EMT and differentiation of coronary smooth muscle cells, 
Pdgfrα-signaling epicardial EMT and cardiac fibroblast formation, Fgfr1 and Fgfr2 epicardial 
EMT, and the Shh-pathway the formation of arterial and venous coronaries. However, cre 
lines based on Gata5 and Wt1 regulatory elements that were used in these experiments 
were recently shown to mediate wide-spread recombination in the early heart. For this 
reason we reinvestigated the requirement of these pathways in epicardial development, 
using conditional gene targeting approaches with a Tbx18cre line which efficiently and 
specifically mediates recombination in the epicardium. Our study shows that the canonical 
Wnt- and Hh-signaling pathways are not only dispensable for epicardial development but that 
they are in fact deleterious for epicardial and myocardial development. Epicardial loss of 
Fgfr1and Fgfr2 does not affect epicardial and coronary vessel development either. However, 
we confirm a requirement for Pdgfrα signaling for mobilization of epicardial cells and 
subsequent differentiation in mature cardiac fibroblasts.  
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Mice 
Mice with a knock-in of the cre-recombinase gene in the Tbx18 locus 
(Tbx18tm4(cre)Akis, synonym: Tbx18cre) were previously generated in the laboratory at 
the Medizinische Hochschule Hannover.1 Mice with loxP sites flanking the Ctnnb1 
locus from exon 2 to exon 6 (Ctnnb1tm2Kem synonym: Ctnnb1fl) were obtained from 
Rolf Kemler (Max-Planck-Institute for Immunobiology and Epigenetics, 
Freiburg/Germany),2 mice with loxP sites flanking exon 3 of the Ctnnb1 locus 
(Ctnnb1tm1Mmt, synonym: Ctnnb1(Ex3)fl) were obtained from Makoto Mark Taketo 
(Kyoto University, Kyoto/Japan).3 Mice with loxP sites flanking exon 2 of the Shh 
locus (Shhtm2Amc, synonym: Shhfl),4 mice with loxP sites flanking exon 4 of the Fgfr1 
locus (Fgfr1tm5.1Sor, synonym: Fgfr1fl),5 mice withloxP sites flanking exons 7 to 10 of 
the Fgfr2 locus (Fgfr2tm1Dor, synonym: Fgfr2fl),6 mice with loxP sites flanking exon 1 of 
the Smo locus (Smotm2Amc, synonym: Smofl),7 mice with a fusion protein of Enhanced 
Yellow Fluorescent Protein (EYFP) and the constitutively active W539L point 
mutation of the Smo protein and a loxP-flanked STOP fragment placed between its 
Gt(ROSA)26Sor promoter and the Smo/EYFP sequence 
(Gt(ROSA)26Sortm1(Smo/YFP)Amc, synonym: SmoGOF),8 mice with loxP sites flanking 
exons 1 to 4 of the Pdgfrα locus (Pdgfrαtm8Sor, synonym: Pdgfrαfl),9 and the double 
fluorescent cre reporter line (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo, synonym: 
R26mTmG)10 were all obtained from the Jackson Laboratory (Bar Harbor, Maine, USA). 
All mice were maintained on an outbred (NMRI) background. 
Embryos for expression analysis were derived form NMRI wildtype mice. Embryos for 
phenotypic analyses were obtained from matings of males triple heterozygous for 
Tbx18cre, R26mTmG and the floxed allele of the pathway mutant, and females 
homozygous for the same floxed allele of the pathway mutant to be analyzed. For 
timed pregnancies, vaginal plugs were checked in the morning after mating and noon 
was designated as embryonic day (E) 0.5. Female mice were sacrified by cervical 
dislocation. Embryos were harvested in PBS, decapitated, fixed in 4% 
paraformaldehyde overnight and stored in 100% methanol at -20oC before further 
use. Genomic DNA prepared from yolk sacs or tail biopsies was used for genotyping 
by PCR. Hans Hedrich, state head of the animal facility, approved the care of 
animals and experiments at Medizinische Hochschule Hannover.  
 
Histological analysis 
For histological stainings embryos were fixed overnight in 4% paraformaldehyde, 
paraffin embedded, and sectioned to 4-µm. Sections were stained with haematoxylin 
and eosin, following standard procedures.  
 
Immunofluorescence 
For immunofluorescence analysis, goat polyclonal antibody against Tbx18 (1:50, C-
20, Santa Cruz), rabbit polyclonal antibody against GFP (1:200 sc-8334, Santa 
Cruz), mouse monoclonal antibody against GFP (1:200, 11 814 460 001, Roche), 
rabbit polyclonal antibody against SM22alpha (Tagln) (1:200, ab14106-100, Abcam), 
rabbit polyclonal antibody against Ctnnb1 (1:400, C2206, Sigma-Aldrich), 
Fluorescein-labeled GSL I – isolectin B4 (1:100, FL-1101, VectorLabs), rabbit 
polyclonal to periostin (1:200, ab14041, Abcam), monoclonal antibody against alpha-
Smooth muscle actin (Acta2), FITC Conjugate (1:200, F3777, Sigma), rabbit 
polyclonal antibody against collagen type IV (1:200, AB756P, Millipore Corp.), rabbit 
polyclonal antibody against ZO1 (Tjp1) (1:200, 61-7300, Zymed Laboratories Inc.) 
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and rabbit polyclonal antibody against Wt1 (1:200, C-19, Santa Cruz) were used as 
primary antibodies.  
Biotinylated goat-anti-rabbit (Dianova, 1:400), biotinylated donkey-anti-goat (Dianova, 
1:400), Alexa488 goat-anti-rabbit (Invitrogen, 1:400), Alexa488 donkey-anti-mouse 
(Invitrogen A21202, 1:400), Alexa-Fluor555 goat-anti-mouse (Invitrogen A-21424, 
1:400) and Alexa-Fluor555 goat-anti-rabbit (Invitrogen A-21428 1:400) were used as 
secondary antibodies. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) 
(Roth). 
Immunofluorescence analysis against Ctnnb1 and Tbx18 was performed on 
cryosections. These were fixed overnight in 4% paraformaldehyde, embedded in 
tissue freezing medium (Jung, Germany), and sectioned to 4-µm. All other 
immunofluorescence analyses were done on 4-µm paraffin sections. All sections 
were pressure cooked for 3 min in antigen unmasking solution (H-3300, Vector 
Laboratories Inc). The signal was amplified using the Tyramide Signal Amplification 
(TSA) system from Perkin-Elmer (NEL702001KT, Perkin Elmer LAS). For double 
staining with GFP, secondary antibody was added during the biotinylated secondary 
antibody step of the TSA protocol.  
 
In situ hybridization analysis 
In situ hybridization analysis on paraffin sections with digoxigenin-labeled antisense 
riboprobes was performed as described.11 Details of used probes upon request.  
 
Proliferation assay 
Cell proliferation was analyzed by incorporation of 5-bromo-2-deoxyuridine (BrdU) on 
5-µm sections of paraffin-embedded specimens similar to previously published 
protocols.12 The quantification of proliferation in Tbx18cre/+;Ctnnb1(Ex3)fl/+ and control 
wildtype littermates was performed with six sections each of four embryos of each 
genotype at E11.5. The BrdU-labeling index was defined as the number of BrdU-
positive cells relative to the total number of nuclei (DAPI counterstain) within the 
epicardium or cell clusters, as indicated.  
 
Quantification of right ventricular GFP+ cells 
Quantification of GFP+ cells was performed on 4-µm paraffin sections of mutant and 
control hearts. Three sections each of three embryos were stained for GFP (as 
described above) and optical fields of a 20x magnification of the right ventricle were 
used to quantify the GFP+ and DAPI+ areas using the ImageJ (NIH) software. The 
calculated relative area (GFP+ versus DAPI+) in the corresponding control genotype 
was set to one and the normalized data expressed as mean±sd. 
 
Epicardial cell culture  
Primary epicardial cells were obtained from right ventricles dissected from E11.5 
hearts. The ventricle was placed onto a gelatin-coated dish in serum-free DMEM 
supplemented with 2 mM Glutamax, 100 units/ml Penicillin, 100 µg/ml Streptomycin 
(Gibco). After 2 days the ventricle was carefully removed using forceps and the 
epithelial monolayer was further cultured in DMEM/Panserin401 (PAN Biotech) with 
or without 10% FCS.  
 
Statistical analysis 
Statistical analyses for BrdU incorporation, capillary density and GFP+ cells were 
performed using the 2-tailed Student’s t-test. Data were expressed as mean±SD. 
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Differences were considered not significant when the P-value was higher than 0.05, 
significant (*) when the P-value was below 0.05, highly significant (**) when the P-
value was below 0.01, and extremely significant (***) if P<0.001.  
 
Image analysis  
Sections were photographed using a Leica DM5000 microscope with Leica 
DFC300FX digital camera. Immunofluorescence of cells, as well as mosaic merge 
pictures of sections where documented using a Leica DMI6000B microscope with a 
Leica FC350FX digital camera. The Leica LAS AF 2.3 software was used to generate 
a mosaic merge of 5x5 single pictures, allowing 10% overlap of neighboring pictures. 
Whole-mount specimens were photographed on Leica M420 with Fujix digital camera 
HC-300Z. All images were processed in ImageJ13 and Adobe Photoshop CS4. 
Part 4   
 Epicardial signaling pathways 
 
90 
References 
 
1. Trowe MO, Shah S, Petry M, Airik R, Schuster-Gossler K, Kist R, Kispert A. Loss of 
Sox9 in the periotic mesenchyme affects mesenchymal expansion and differentiation, 
and epithelial morphogenesis during cochlea development in the mouse. Dev Biol. 
2010;342:51-62. 
2. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, 
Boussadia O, Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated 
deletion results in dramatic brain malformation and failure of craniofacial 
development. Development. 2001;128:1253-1264. 
3. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. 
Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. 
EMBO J. 1999;18:5931-5942. 
4. Dassule HR, Lewis P, Bei M, Maas R, McMahon AP. Sonic hedgehog regulates 
growth and morphogenesis of the tooth. Development. 2000;127:4775-4785. 
5. Hoch RV, Soriano P. Context-specific requirements for Fgfr1 signaling through Frs2 
and Frs3 during mouse development. Development. 2006;133:663-673. 
6. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. Conditional 
inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the 
regulation of osteoblast function and bone growth. Development. 2003;130:3063-
3074. 
7. Long F, Zhang XM, Karp S, Yang Y, McMahon AP. Genetic manipulation of 
hedgehog signaling in the endochondral skeleton reveals a direct role in the 
regulation of chondrocyte proliferation. Development. 2001;128:5099-5108. 
8. Jeong J, Mao J, Tenzen T, Kottmann AH, McMahon AP. Hedgehog signaling in the 
neural crest cells regulates the patterning and growth of facial primordia. Genes Dev. 
2004;18:937-951. 
9. Tallquist MD, Soriano P. Cell autonomous requirement for PDGFRalpha in 
populations of cranial and cardiac neural crest cells. Development. 2003;130:507-
518. 
10. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre 
reporter mouse. Genesis. 2007;45:593-605. 
11. Moorman AF, Houweling AC, de Boer PA, Christoffels VM. Sensitive nonradioactive 
detection of mRNA in tissue sections: novel application of the whole-mount in situ 
hybridization protocol. J Histochem Cytochem. 2001;49:1-8. 
12. Bussen M, Petry M, Schuster-Gossler K, Leitges M, Gossler A, Kispert A. The T-box 
transcription factor Tbx18 maintains the separation of anterior and posterior somite 
compartments. Genes Dev. 2004;18:1209-1221. 
13. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image 
analysis. Nat Methods. 2012;9:671-675. 
 
 
Part 4   
 Epicardial signaling pathways 
   91 
Supplemental Online Figures 
 
 
 
 
 
Online Figure I. Tbx18 expression and Tbx18cre-mediated recombination in the 
epicardium of E10.5 hearts. (A, A’, A’’) Co-immunofluorescence analysis for 
expression of Tbx18 (red) and Col4 (green) with nuclear counterstaining (blue) on a 
transverse cryosection of an E10.5 wildtype heart. Tbx18 is found in the nucleus of 
all epicardial cells that are delineated by the ColIV-positive basal lamina. (B, B’, B’’) 
Immunofluorescence analysis for expression of membrane-bound GFP (green) of the 
recombination reporter Rosa26mTmG on a transverse heart section of an E10.5 
Tbx18cre/+;Rosa26mTmG/+ embryo. All epicardial cells express the GFP reporter. 
Magnified regions of the right ventricle (A’, B’) and of the left ventricle (A’’, B’) are 
indicated by rectangles (in A, B). Note that the overview figures were composed of 
25 individual images. e, epicardium; la, left atrium; lv, left ventricle; oft, outflow tract; 
ra, right atrium; rv, right ventricle. 
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Online Figure II. Canonical Wnt signaling in epicardial development. In situ 
hybridization analysis for expression of Axin2, a bona fide transcriptional target of the 
canonical Wnt signaling pathway, on E9.5 sagittal as well as on E12.5 and E14.5 
transverse sections of wildtype hearts. Rectangles display the regions shown in 
higher magnification in the images below at the indicated stages. Black arrows point 
to the epicardium. Axin2 expression is not detected in the proepicardium and the 
epicardium. Note positive control regions within the hearts (e.g. the atrioventricular 
cushion tissue and valves). avc, atrioventricular canal; lv, left ventricle; pe, 
proepicardium; rv, right ventricle. 
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Online Figure III. Absence of Ctnnb1 in the (pro-)epicardium of 
Tbx18cre/+;Rosa26mTmG/+;Ctnnb1fl/fl embryos. Co-immunofluorescence analysis of 
Ctnnb1 (red) and the recombination reporter GFP (green) in sagittal sections through 
the (pro-) epicardium at E9.5 and transverse sections of the right ventricle at E14.5 in 
control (Tbx18cre/+;Rosa26mTmG/+;Ctnnb1fl/+) and mutant 
(Tbx18cre/+;Rosa26mTmG/+;Ctnnb1fl/fl) embryos. Note the absence of Ctnnb1 
expression in the mutant proepicardium and epicardium compared to the control. 
White arrows point to the epicardium. pe, proepicardium; myo, myocardium; rv, right 
ventricle. 
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Online Figure IV. Epicardial loss of Ctnnb1 does not affect EPDCs and 
coronary vessel formation. Immunofluorescence analysis of the recombination 
reporter GFP (green) and coronary vessel endothelium (IB4, red) in transverse 
sections of the heart at E13.5 and E18.5 in control 
(Tbx18cre/+;Rosa26mTmG/+;Ctnnb1fl/+) and mutant (Tbx18cre/+;Rosa26mTmG/+;Ctnnb1fl/fl) 
embryos. Quantification of EMT (GFP+ area vs DAPI+ area) at 13.5 (P=0.9) and at 
E18.5 (P=0.2) and vessel density (number of IB4+ vessels per area) at E18.5 (P=0.5) 
in the right ventricle does not reveal changes in the mutant.  
Part 4   
 Epicardial signaling pathways 
   95 
 
 
Online Figure V. Ctnnb1-deficient epicardial cells can be induced to 
differentiate into SMCs. Cellular analysis of epicardial outgrowths of explants of 
right ventricles of control (Tbx18cre/+;Ctnnb1fl/+) and Ctnnb1-deficient 
(Tbx18cre/+;Ctnnb1fl/fl) embryos. After 2 days of culture under serum-free conditions 
ventricles were removed and epicardial outgrowths cultures for another 2 days in a 
1:1 mixture of DMEM and Panserin401 without serum (A) or they were cultured for 4 
days in a 1:1 mixture of DMEM and Panserin401 containing 10% FCS (B). 
Immunofluorescence analysis for Ctnnb1, Tjp1, Wt1 and Acta2 (red) with nuclear 
counter staining (blue). Shown are representative higher magnification of whole 
explants. Note the loss of Ctnnb1 immunoreactivity in the mutant cells. Tjp1, Wt1 and 
Acta2 stainings in the mutant are indistinguishable to the control. After addition of 
10% FCS both normal and mutant epicardial cells underwent EMT and differentiated 
into SMCs. 
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Online Figure VI. Constitutive Wnt-signaling in the epicardium leads to 
increased proliferation. (A) BrdU incorporation was analyzed by 
immunofluorescence on E11.5 transverse heart sections of control 
(Tbx18cre/+;Rosa26mTmG/+)and Tbx18cre/+;Rosa26mTmG/+;Ctnnb1(Ex3)fl/+ embryos. 
Rectangles display the regions shown in higher magnification. Arrows point to the 
epicardium, the quadrant marks an epicardial cell cluster. (B) Quantification of the 
BrdU labeling index shows significant enhanced proliferation in the mutant epicadium 
(P=0.003) and cell clusters (P=0.0004).  
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Online Figure VII. Hh-signaling in epicardial development. In situ hybridization 
analysis for expression of Ptch1, a bona fide transcriptional target of the Hh-signaling 
pathway, on E9.5 sagittal as well as on E12.5 and E14.5 transverse sections of 
wildtype hearts. Black rectangles display the regions shown in higher magnification in 
the images below at the indicated stages. Black arrows point to the epicardium. 
Ptch1 expression is not detected in the proepicardium and the epicardium. Note 
positive control regions within the sections, shown as blue insets (e.g. notochord and 
floorplate). avc, atrioventricular canal; lv, left ventricle; nf, notochord/floorplate; pe, 
proepicardium; rv, right ventricle. 
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Online Figure VIII. Epicardial loss of Smo does not affect EPDCs and coronary 
vessel formation. Immunofluorescence analysis of the recombination reporter GFP 
(green) and of the coronary vessel endothelium (IB4, red) in transverse sections of 
the heart at E14.5 and E18.5 in control (Tbx18cre/+;Rosa26mTmG/+;Smofl/+) and mutant 
(Tbx18cre/+;Rosa26mTmG/+;Smofl/fl) embryos. Quantification of EMT (GFP+ area vs 
DAPI+ area) at 14.5 (P=0.7) and at E18.5 (P=0.4) and vessel density (number of IB4+ 
vessels per area) at E18.5 (P=0.1) in the right ventricle does not reveal changes in 
the mutant. 
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Online Figure IX. Expression of genes encoding Hh-ligands in epicardial 
development. In situ hybridization analysis for expression ofShh, Dhh and Ihh on 
E9.5 sagittal as well as on E12.5 and E14.5 transverse sections of wildtype hearts. 
Black rectangles display the regions shown in higher magnification in the images 
below at the indicated stages. Black arrows point to the epicardium. Shh, Dhh and 
Ihh expression is not detected in the proepicardium and the epicardium. Note positive 
control regions within the sections, shown as blue insets (e.g. Shh in the notochord 
and floorplate; Ihh in the rib primodium). avc, atrioventricular canal; lu, lung; lv, left 
ventricle; nf, notochord/floorplate; pe, proepicardium; rp, rib primodium; rv, right 
ventricle. 
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Online Figure X. Epicardial loss of Shh does not affect EPDCs and coronary 
vessel formation. Immunofluorescence analysis of the recombination reporter GFP 
(green) and of the coronary vessel endothelium (IB4, red) in transverse sections of 
the heart at E14.5 and E18.5 in control (Tbx18cre/+;Rosa26mTmG/+;Shhfl/+) and mutant 
(Tbx18cre/+;Rosa26mTmG/+;Shhfl/fl) embryos. Quantification of EMT (GFP+ area vs 
DAPI+ area) at E14.5 (P=0.4) and at E18.5 (P=0.5) and vessel density (number of 
IB4+ vessels per area) at E18.5 (P=0.1) in the right ventricle does not reveal changes 
in the mutant. 
 
 
Part 4   
 Epicardial signaling pathways 
   101 
 
 
 
Online Figure XI. Fgf-signaling in epicardial development. In situ hybridization 
analysis for expression of Etv4, a bona fide transcriptional target of the Fgf-signaling 
pathway, on E9.5 sagittal as well as on E12.5 and E14.5 transverse sections of 
wildtype hearts. Boxed areas are shown in higher magnification in the lower row. 
Black arrows point to the epicardium. Etv4 expression is not detected in the 
proepicardium and the epicardium. avc, atrioventricular canal; lv, left ventricle; pe, 
proepicardium; rv, right ventricle. 
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Online Figure XII. Combined epicardial loss of Fgfr1 and Fgfr2 does not affect 
EPDCs and coronary vessel formation. Immunofluorescence analysis of the 
recombination reporter GFP (green) and of the coronary vessel endothelium (IB4, 
red) in transverse sections of the heart at E18.5 in control 
(Tbx18cre/+;Rosa26mTmG/+;Fgfr1fl/+;Fgfr2fl/+) and mutant 
(Tbx18cre/+;Rosa26mTmG/+;Fgfr1fl/fl;Fgfr2fl/fl) embryos. Quantification of EMT (GFP+ 
area vs DAPI+ area) (P=0.6) and vessel density (number of IB4+ vessels per area) 
(P=0.2) in the right ventricle does not reveal changes in the mutant. 
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Online Figure XIII. Epicardial loss of Pdgfrα leads to a reduced number of 
EPDCs. Immunofluorescence analysis of the recombination reporter GFP (green) 
and of the coronary vessel endothelium (IB4, red) in transverse sections of the heart 
at E14.5 and E18.5 in control (Tbx18cre/+;Rosa26mTmG/+;Pdgfrαfl/+) and mutant 
(Tbx18cre/+;Rosa26mTmG/+;Pdgfrαfl/fl) embryos. Quantification of EMT (GFP+ area vs 
DAPI+ area) at 14.5 (P=0.02) and at E18.5 (P=0.002) reveals a reduction of EPDCs 
whereas the vessel density (number of IB4+ vessels per area) (P=0.7) at E18.5 in the 
right ventricle is unchanged. 
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Abstract  
 
Rationale:  
The mesothelial lining of the body cavities and the urothelial lining of the urinary tract are 
highly specialized epithelia that protect the underlying tissues from mechanical stress and 
toxic fluids. The development of these epithelia from simple precursors and the molecular 
characteristics of the mature tissues are poorly analyzed. 
 
Objective:  
To determine the spatiotemporal expression of Upk3b and analyze its function for 
differentiation and integrity of the mesothelial lining of the body cavities and the urothelial 
lining of the urinary tract. 
 
Methods and Results:  
Using in situ hybridization analysis on sections and in whole-mount specimens we show 
specific expression of Upk3b both in development as well as under homoeostatic conditions, 
in adult mice in the mesothelial lining of the body cavities including the epicardium and 
pericardium, as well as in the urothelium lining the urinary tract. We generated a creERT2 
knock-in allele of Upk3b by homologous recombination in embryonic stem cells and show 
that it represents a null allele despite the lack of cre expression from the mutated locus. 
Morphological, histological and molecular analyses of Upk3b-deficient mice do not detect 
changes in differentiation or integrity of the urothelium and the mesothelia that cover internal 
organs in Upk3b-deficient mice. 
 
Conclusions:  
We suggest that Upk3b does not have a unique function in development and homeostasis of 
urothelia and mesothelia in the mouse. 
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Introduction 
 
The lining of the urinary tract, i.e. of the collecting duct system of the kidney, the ureter, the 
urinary bladder and the urethra, represents a highly specialized epithelium that is both 
flexible and tight to accommodate the varying intraluminal pressure and the toxicity of the 
urinary fluid. A compelling structural feature of this urothelium is the presence of an 
elaborated surface barrier, which is composed of extracellular matrix as well as of integral 
membrane proteins. Members of the uroplakin protein family have been identified as crucial 
building units of this surface barrier that exhibits an almost crystalline organization (urothelial 
plaques).1 Uroplakins can be subdivided into three sub-groups that consist of Upk1a/Upk1b, 
Upk2 and Upk3a/Upk3b. The sub-groups are distinguished by the number of transmembrane 
domains (TMD), by their glycosylation pattern and by the size of their cytoplasmic domain. 
Upk3a and Upk3b proteins are characterized by a single TMD, a glycosylated N-terminal 
luminal domain and a relatively large cytoplasmic domain, that may anchor the urothelial 
plaques to the cytoskeleton.2,3 Upk3a and Upk3b can form heterodimeric complexes with 
Upk1b, whereas Upk1a heterodimerizes with Upk2.3,4 Functional analyses by gene targeting 
have uncovered a crucial role for Upk2 and Upk3a in maintaining the impermeability of the 
urothelium.5,6 In both mutants renal dysfunction and hydronephrosis develop, i.e. fluid-
mediated dilatation of the renal pelvis, most likely due to a reduction of urothelial plaques and 
urinary leakage. Analysis of urothelial function of Upk1a, Upk1b and Upk3b has not yet been 
performed. 
A restriction of uroplakin function to the epithelial lining of the urinary tract was recently 
questioned by the finding in microarray analyses that Upk3b is enriched in peritoneal, pleural 
and pericardial mesothelia of mice. Subsequent in situ hybridization analysis confirmed 
Upk3b expression in the mesothelial linings of the lung and heart, liver, kidney, spleen, 
intestine, testis and thymus in adult mice.7 Mesothelia are monolayers of flattened 
squamous-like epithelial cells that line the pleural, pericardial and peritoneal cavities of the 
chest and the abdomen, respectively. They possess a parietal layer that covers the body wall 
and a visceral layer that covers the organ in the respective cavity. Adult mesothelia produce 
a lubricating fluid that allows the internal organs to slide over each other. During 
development individual cells of the mesothelia can undergo a mesenchymal transition and 
leave the epithelial integrity, invade the underlying space and differentiate into fibroblasts and 
smooth muscle cells. The visceral pericardium, also known as epicardium, has been 
particularly well studied in recent years since it turned out to provide precursors for the 
cardiac fibroskeleton as well as smooth muscle cells of the coronary vasculature.8 Some 
studies reported endothelial and myocardial fates of epicardial cells9,10 although these 
findings were criticized for technical ambiguities.11,12 
Identification of Upk3b expression in mesothelial tissues raises the interesting possibility that 
mesothelia and urothelia share structural features that may relate to efficient sealing of 
luminal spaces. To gain deeper insight into the role of Upk3b in these tissues, we wished to 
determine its expression both in development and homeostasis and analyze its functional 
requirement using gene-knock-out technology in mice.  
Here, we provide a detailed expression analysis of Upk3b and show that Upk3b-deficiency 
does not affect the development and integrity of the urothelia and mesothelia in mice. 
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Material and methods 
 
Mice 
For the generation of a creERT2 knock-in allele of Upk3b a targeting vector was constructed 
to insert a CreERT2 coding region (Addgene plasmid 14797)13 followed by a PGK-neo 
cassette flanked by loxP sites14 into the start codon of the Upk3b locus (Figure 3). The 
integrity of the targeting vector was confirmed by restriction mapping and sequencing before 
the plasmid was linearized and electroporated into 129/SvCast ES cells. 24 h after 
electroporation, selection of transgenic clones was started by addition of 125 µg/ml G418 to 
the medium. Surviving colonies were expanded and subsequently screened for correct 
integration of the 3'-homology arm by PCR and for correct 5'-integration by Southern blot 
analysis. Three ES clones with verified homologous recombination of both arms were 
microinjected into CD1 mouse morulae. Chimeric males were mated to a cre deleter line 
(Tbx3tm1.1(cre)Vmc)15 to remove the neo cassette. The double fluorescent cre reporter line 
(Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo, synonym: R26mTmG)16 was obtained from the Jackson 
Laboratory (Bar Harbor, Maine, USA). All mice were maintained on an outbred (NMRI) 
background.  
Embryos for expression analysis were derived form NMRI wild-type mice. The cell fate was 
analyzed in Upk3bcreERT2/+;Rosa26mTmG/+ embryos, obtained from matings of males double 
heterozygous for Upk3bcreERT2 and R26mTmG alleles and females heterozygous for 
Upk3bcreERT2. In the latter case, tamoxifen (Sigma) was dissolved in ethanol at 100 mg/ml and 
then emulsified in corn oil (Sigma) to a final concentration of 12.5 mg/ml. 4 mg of tamoxifen 
were intraperitoneally injected into mice at gestation day 9.5. For timed pregnancies, vaginal 
plugs were checked in the morning after mating and noon was designated as embryonic day 
(E) 0.5. Female mice were sacrified by cervical dislocation. Embryos and organs were 
harvested in PBS, decapitated, fixed in 4% paraformaldehyde overnight and stored in 100% 
methanol at -20oC before further use. Genomic DNA prepared from yolk sacs or tail biopsies 
was used for genotyping by PCR. H. Hedrich, state head of the animal facility, approved the 
care of animals and experiments at Medizinische Hochschule Hannover.  
 
 
Histological analysis 
For histological stainings embryos were fixed overnight in 4% paraformaldehyde, paraffin 
embedded, and sectioned to 4-µm. Sections were stained with haematoxylin and eosin 
following standard procedures.  
 
 
Immunofluorescence 
For immunofluorescence analysis rabbit polyclonal antibody against GFP (1:200 sc-8334, 
Santa Cruz), mouse monoclonal antibody against GFP (1:200,11 814 460 001, Roche), 
rabbit polyclonal antibody against SM22alpha (Tagln) (1:200, ab14106-100, Abcam), 
Fluorescein labeled GSL I – isolectin B4 (1:100, FL-1101, VectorLabs), rat monoclonal 
antibody against endomucin (Emcn) (1:2, a kind gift of D. Vestweber, MPI Münster; 
Germany), rabbit polyclonal against periostin (1:200, Abcam, ab14041), mouse monoclonal 
antibody against alpha-Smooth muscle actin (Acta2), FITC Conjugate (1:200, F3777, Sigma) 
and mouse monoclonal antibody against MF20 (1:200, Hybridoma Bank University of Iowa) 
were used as primary antibodies.  
Biotinylated goat-anti-rabbit (Dianova, 1:400), Alexa488 goat-anti-rabbit (Invitrogen, 1:400), 
Alexa488 donkey-anti-mouse (Invitrogen A21202, 1:400), Alexa-Fluor555 goat-anti-mouse 
(Invitrogen A-21424, 1:400) and Alexa-Fluor555 goat-anti-rabbit (Invitrogen A-21428 1:400) 
were used as secondary antibodies. Nuclei were stained with 4’,6-diamidino-2-phenylindole 
(DAPI) (Roth). 
Immunofluorescence analysis was done on 4-µm paraffin sections. All sections were 
pressure cooked for 3 min in antigen unmasking solution (H-3300, Vector Laboratories Inc). 
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The signal was amplified using the Tyramide Signal Amplification (TSA) system from Perkin-
Elmer (NEL702001KT, Perkin Elmer LAS).  
 
 
In situ hybridization analysis  
In situ hybridization analysis on 10-µm paraffin sections and on whole embryos with 
digoxigenin-labeled antisense riboprobes was performed as described.17 
 
 
Semi-quantitative reverse transcription PCR  
For semiquantitative analysis of Upk3b expression three hearts each of wildtype, 
heterozygous and homozygous E12.5 embryos were pooled. RNA was extracted with 
RNAPure reagent (Peqlab) and DNaseI treated for 30min at 37°C. RNA was reverse 
transcribed with RevertAid H-minus M-MuLV Reverse Transcriptase (Fermentas). For semi-
quantitative PCR, the pools were adjusted to yield the same Gapdh intensity at the mid-
logarithmic phase and the Upk3b PCR was performed on these pools. Quantification was 
performed with ImageJ.18 
 
 
Image analysis  
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX 
digital camera. Whole-mount specimens were photographed on Leica M420 with Fujix digital 
camera HC-300Z. All images were processed in ImageJ18 and Adobe Photoshop CS4. 
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Results 
 
Upk3b is expressed in the urothelium and in mesothelial tissues during embryonic 
development 
To determine the expression pattern of Upk3b during embryonic development, we performed 
in situ hybridization analysis on E9.5 to E16.5 mice (Figure 1). In E9.5 embryos expression of 
Upk3b was detected in the urogenital ridge, the proepicardium, the dorsal mesocardium and 
in single epicardial cells that were attached to the ventricular myocardium at this stage. At 
E10.5, Upk3b expression lined the contiguous epicardium in addition to all mesothelial linings 
of the body cavity. At E12.5 and subsequent embryonic stages, all mesothelial linings (i.e 
epicardium and pericardium, pleura, and peritoneum) expressed Upk3b. From E14.5 on, the 
epithelial lining of the developing urinay tract including the renal pelvis, the lumen of the 
bladder and the ureter were positive for Upk3b expression as well. 
 
Upk3b is expressed in the pericardium and in the urothelium of adult mice  
To test whether expression of Upk3b was maintained into adulthood, we performed in situ 
hybridization analysis on sections of organs obtained from 6-month old mice (Figure 2). In 
the heart Upk3b was confined to the epicardium that lined all chambers as well as in the 
pericardium covering the great coronary vessels. In the urinary system, the multi-layered 
urothelium lining the lumen of the renal pelvis, the ureter and the bladder expressed Upk3b 
in addition to the single layered outer peritoneal lining of these organs. 
 
Generation of a creERT2 knock-in allele of Upk3b by homologous recombination in ES 
cells  
To elucidate the role of Upk3b both in the development and in the maintenance of urothelial 
and mesothelial tissues in adulthood, we wished to generate an Upk3b knock-in allele 
allowing tamoxifen inducible expression of the cre-recombinase gene under the control of 
endogenous Upk3b control elements (Figure 3). Mice with correct integration of a creERT2 
expression cassette in the Upk3b locus were obtained and subsequently tested for 
functionality of the creERT2 protein by injection of tamoxifen into pregnant 
Upk3bcreERT2/+;Rosa26mTmG/+ dams at E9.5. To our surprise, in situ hybridization did not detect 
expression of the cre transcript in the epicardium, the pericardium or ureteric urothelium of 
E15.5 embryos although expression of Upk3b was still easily detected in these organs. Since 
this assay cannot unambiguously exclude the presence of low levels of Cre expression, we 
additionally performed a reporter gene analysis using GFP immunofluorescence to test for 
recombination on neighboring sections. Expression of GFP was not detected in any of the 
analyzed tissues (Figure 4 and data not shown). We, therefore, conclude that creERT2 is not 
expressed in a correct manner from the Upk3bcreERT2/+ allele.  
 
Upk3bcreERT2/creERT2 mice are Upk3b null mutants  
To test if Upk3b is deleted in the Upk3bcreERT2/+ allele, we performed in situ hybridization 
analysis for the Upk3b-3’-untranslated region on transverse sections of the heart and ureter 
in E18.5 embryos homozygous for the Upk3bcreERT2 allele. Expression of Upk3b was neither 
detected in mesothelia (e.g. lung, pleuropericardial membrane and epicardium) nor in the 
urothelium of the ureter. Furthermore, semiquantitative RT-PCR analysis of E12.5 isolated 
hearts derived from wildtype, heterozygous and homozygous mutant embryos confirmed the 
absence of Upk3b mRNA in Upk3bcreERT2/creERT2 embryos. We conclude that 
Upk3bcreERT2/creERT2 mice represent Upk3b null mutants, and thus, can be analyzed for 
phenotypic consequences of loss of Upk3b. 
 
Upk3b is dispensable for development and integrity of the heart and the urinary 
bladder  
Upk3bcreERT2/creERT2 mice were born in the expected Mendelian ratio, reached sexual maturity 
and became fertile and were unaltered in their behavior at 6-months of age. Morphologically, 
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the mutants exhibited no differences in the appearance of internal organs of the chest and 
the abdomen (data not shown). On histological sections the heart seemed unaffected; the 
ventricular wall thickness was normal and the integrity of the septa, valves and the 
epicardium was preserved (Figure 6). 
Since epicardial cells give rise to the smooth muscle and fibroblast lineages, thus, contribute 
to the formation of the coronary vessels and fibrous skeleton of the heart, we analyzed by 
immunofluorescence of marker proteins the arrangement of vessels (isolectin-B4 endothelial 
staining), smooth muscle cells (transgelin (Tagln, also known as Sm22)) and of interstitial 
and perivascular fibroblasts (periostin (Postn)). Expression and distribution of these markers 
was indistinguishable between mutant and wildtype hearts, demonstrating that deletion of 
Upk3b is irrelevant for the integrity of the coronary vasculature and the cardiac fibrous 
skeleton at this level of resolution. Immunofluorescence analysis of myocardial marker MF20 
revealed a normal myocardium excluding changes of the trophic function of the mutant 
epicardium as well.  
The urinary bladder appeared normal on histological sections and the urothelium and the 
detrusor muscle were in sound condition. Given that the main function of the urinary bladder 
is to protect the underlying detrusor from the toxicity of the urine, we analyzed whether the 
urothelium (uroplakin1b (Upk1b)) was intact, and whether the muscle layer (transgelin, 
Tagln, also known as Sm22)) fibroblasts (periostin, Postn) and endothelial cells of the 
vessels (endomucin, Emcn) were affected. Expression of the urothelial, endothelial, fibroblast 
and muscle markers was indistinguishable between mutant and wildtype mice, indicating that 
Upk3b is dispensable for normal urinary bladder formation and homeostasis. 
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Discussion 
 
Upk3b is expressed in the urothelium and mesothelial tissues during embryonic 
development and in adulthood 
Our detailed expression analysis confirmed the urothelial presence of Upk3b. It additionally 
showed that onset of Upk3b expression in the epithelium of the urinary tract slightly precedes 
the onset of urine production in the renal pelvis around E16.019 compatible with the function 
of urothelial plaques to generate a permeability barrier against the toxic effects of the urine.1  
Our expression analysis for the fist time identified Upk3b in all mesothelia from E9.5 to 
adulthood. Mesothelia are thought to be important for the protection of the underlying tissues, 
thus are likely to achieve a high degree of impermeability and flexibility at the same time. In 
analogy to the urothelium the occurrence of “mesothelial plaques” seems possible. To test 
this hypothesis, we performed additional expression analysis for the key components of the 
urothelial plaques Upk1a, Upk2 and Upk3a. However, this analysis did not detect expression 
of any of these genes in mesothelial development (data not shown) making the formation of 
“mesothelial plaques” unlikely at this point. Nevertheless, luminal N-glycosylation of Upk3b 
protein3 might account for the lubrication of mesothelial surfaces by binding of extracellular 
fluids. Furthermore, the potential interaction of Upk3b’s cytoplasmatic domain with the 
cytoskeleton may participate in the maintenance of the apico-basal polarity of mesothelial 
tissues. 
 
Upk3bcreERT2 represents a Upk3b null allele but does not allow cre-mediated 
recombination  
Our targeting construct was designed to allow for tamoxifen-controllable mesothelial and 
urothelial expression of a creERT2 fusion protein. However, to our surprise we failed to 
detect expression and activity of this protein in mutant animals. At this point, we do not know 
the reasons that might have caused this problem. We assume that promotor accessibility 
might be affected by the knocked-in sequence, and silencing of the locus resulted. 
Furthermore, reduced transcript stability, due to reduced polyadenylation, altered 5’- and 3’-
untranslated regions and overall translational activity are possible factors for the lack of 
creERT2 protein. Finally, potential mutations acquired during the ES cell culture leading to 
non-sense mediated decay, cannot be excluded. Nonetheless, Upk3b was no longer 
expressed from the mutant allele allowing the characterization of the phenotypic 
consequences of Upk3b loss in mice.  
 
Upk3b is dispensable for normal heart and urinary bladder formation.  
The specific expression of Upk3b in all mesothelia of the developing murine embryo pointed 
towards a possible role in the separation of the body cavities, in which growth of mesothelia 
is of crucial importance.20 Differences in the separation of the chest and abdomen and of 
pleural, pericardial and peritoneal cavities as well as the appearance of internal organs were 
not detected in the mutants (data not shown), excluding an important function for Upk3b in 
the formation of mesothelia.  
Mesothelial cells of the heart, lung, intestine and liver can give rise to vascular smooth 
muscle cells and fibroblasts.8,21–26 Our analysis of the epicardium, the best studied 
mesothelial tissue in vertebrates, did neither detect changes in the mesenchymal transition of 
epicardial cells nor in the subsequent differentiation into smooth muscle cells and cardiac 
fibroblasts. Furthermore, we noticed that the ventricular myocardium was of normal thickness 
and the coronary vasculature was well-elaborated excluding both a cellular and trophic role 
of Upk3b in epicardial development.  
Interestingly, adult mesothelial cells of the omentum and epicardium have been reported to 
contribute to vascular smooth muscle cell and fibroblast lineages under chronic and/or acute 
injury conditions.27,28 In peritoneal sclerosis, a submesothelial thickening of abdominal 
membranes29 and in myocardial infarction new fibroblasts arise from the injured 
epicardium.30 Often, these fibrotic conditions are additionally associated with inflammatory 
Part 5   
Upk3b in urothelia and mesothelia 
   113 
processes. As the molecular mechanisms underlying this regenerative capacity derive from 
the reactivation of embryonic gene programs,28,31 that were unaffected in Upk3b-deficient 
embryos, we deem it unlikely that Upk3b is implicated in the regenerative capacity of adult 
mesothelia. However, future work should test a requirement for Upk3b in pathological 
conditions in a more detailed fashion.  
In urothelial plaques, Upk3b is present at low levels, amounting usually to less than 10% of 
Upk3a, the major plaque component. In Upk3a-deficient mice, urothelial plaques are present 
but smaller in size, Upk3b is up-regulated relative to other uroplakins.53 Furthermore, co-
immunoprecipitation experiments showed specific binding of Upk3b to Upk1b, the binding 
partner of Upk3a in plaques. Together with our finding that the urinary tract appears normal 
in Upk3b-deficient mice, this suggests that Upk3b acts redundantly with Upk3a in the 
urothelium. Analysis of mice double mutant for Upk3a and Upk3b may address the combined 
function of both factors in the future.  
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Figures and legends 
 
 
 
 
 
 
Figure 1. Upk3b expression in embryonic development. In situ hybridization analysis of 
Upk3b expression in whole wildtype embryos (A and B) and on sagittal embryo sections (D 
through J). (A through E) Overview images of embryos, anterior is up, dorsal is to the right. 
(F through J) Higher magnification images of the regions marked by open rectangles (in A 
through E). Stages are as indicated. Arrows point to the epicardium. a, atrium; bl, urinary 
bladder; bw, body wall; dm, dorsal mesocardium; g, gut; h, heart; ki, kidney; lb, lung bud; li, 
liver; lu, lung; ugr, urogenital ridge; pe, proepicardium; ppm, pleuropericardial membrane; v, 
ventricle. 
Part 5   
Upk3b in urothelia and mesothelia 
   117 
 
 
 
 
 
 
 
 
Figure 2. Upk3b expression in adult tissues. In situ hybridization analysis of Upk3b 
expression on sections of the adult heart (A and D), the urinary bladder (B and E) and the 
kidney (C and F). (A through C) Overview images of whole organ sections, (D through F) 
higher magnification images of the regions marked by open rectangles (in A through C). 
The arrow points to the epicardium. bl, urinary bladder; cv, coronary vessel; la, left atrium; lu, 
urinary bladder lumen; lv, left ventricle; m, urinary bladder mesothelium; ra, right atrium; rp, 
renal pelvis; rv, right ventricle; u, urothelium. 
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Figure 3. Generation and confirmation of a creERT2 knock-in allele of Upk3b. (A) 
Scheme of the targeted insertion of a creERT2 recombinase gene/loxP-flanked neomycin 
selection cassette in the Upk3b locus. Exons are shown in black, regions for homologous 
recombination in red. Screening for clones with correct integration of the creERT2/neo 
cassette was performed using a PCR for the 3'-region, primers are indicated in pink. A 
BamHI restriction fragment length polymorphism (RFLP) with the indicated 5'-probe was 
used to check for correct 5'-integration (B), and a long-range PCR to verify the correct 3’-
integration (C) of the targeting vector.ATG, transcriptional start codon; B, BamHI; creERT2, 
cre recombinase fused to a triple mutant form of the human estrogen receptor expression 
cassette; kbp, kilo base pairs; loxP, locus of X-over P1; Neo, neomycin resistance gene; pA, 
polyadenylation signal; pgk, phosphoglycerate kinase I promoter. 
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Figure 4. Upk3bcreERT2/+ mice neitherexpress cre nor mediate recombination of loxP-
flanked sequences in the ureter and in the epicardium. Pregnant mothers were injected 
at E9.5 with tamoxifen and E15.5 Upk3bcreERT2/+;Rosa26mTmG/+ embryos were analyzed by in 
situ hybridization for expression of Upk3b and cre on transverse sections of the ureter (A 
and B) and the heart (D and E). Immunofluorescence analysis of the lineage marker GFP 
was performed on transverse sections of the ureter (C) and the heart (F). Arrows point to the 
epicardium. lv, left ventricle; ppm, pleuropericardial membrane; rv, right ventricle; u, ureter. 
Nuclei are counter-stained with 4',6-diamidino-2-phenylindole.  
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Figure 5. Upk3bcreERT2/creERT2 mice are Upk3b null mutants. In situ hybridization analysis for 
expression of Upk3b and cre on transverse sections of an E18.5 heart (A through E) and 
ureter (B through F) in wildtype and homozygous knock-out embryos. (G) Semiquantitative 
RT-PCR analysis of E12.5 isolated hearts derived from wildtype, heterozygous and knock-
out (Upk3bcreERT2/creERT2) animals. lu, lung; ppm, pleuropericardial membrane; ra, right artrium; 
rv, right ventricle; u, ureter. 
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Figure 6. Upk3b is dispensable for normal heart formation. Hematoxylin and eosin 
staining (H&E) and immunofluorescence analysis of markers of capillary endothelia (IB4), 
cardiomyocytes (MF20), fibroblasts (Postn) and coronary smooth muscle cells (Tagln) on 
sections of 6-month old hearts of wildtype and homozygous knock-out mice. Magnified areas 
are indicated with rectangles. Arrows point to the epicardium. cv, coronary vessel; lv, left 
ventricle; rv, right ventricle.Nuclei are counter-stained with 4',6-diamidino-2-phenylindole.  
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Figure 7. Upk3b is dispensable for normal urinary bladder formation. Hematoxylin and 
eosin staining (H&E) and immunofluorescence analysis for markers of the urothelium 
(Upk1b), vessel endothelium (Emcn), fibroblasts (Postn) and smooth muscle cells (Tagln) on 
sections of the bladder of 6-month old wildtype and homozygous knock-out animals. 
Magnified areas are indicated with rectangles. d, detrusor; u, urothelium.Nuclei are counter-
stained with 4',6-diamidino-2-phenylindole.  
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Concluding remarks  
 
In vertebrates the formation of the epicardium and addition of epicardium-derived cells to the 
developing heart is important for establishing a functional coronary vasculature and 
maturation of the myocardium. In this study, smooth muscle cells, perivascular and interstitial 
fibroblasts were confirmed as epicardium-derived cells in the right ventricle. This canonical 
epicardial lineage has been identified in zebrafish73, chick10,16,23,24 and mouse28,29,74. Further 
epicardial contribution to this myocardial and endothelial lineages was suggested by 
deployment of regulatory sequences of the epicardial marker genes Wt1 and Tbx18,28,29, but 
was disproven in this study and in independent publications.41,73 Only recently two novel 
marker genes, Scleraxis (Scx) and Semaphorin 3D (Sema3D), have been identified in a 
subset of proepicardial cells, only overlapping in part with Wt1 and Tbx18 expressing cells. 
Interestingly, Scx and Sema3D labelled cells give rise to myocardial and endothelial cells 
additionally to the classical epicardial cell fates, in addition to the canonical epicardial 
lineage.74 The proepicardium is obviously compartmentalized into genetically distinct 
subpopulations, shown by the largely non-overlapping expression of Wt1/Tbx18 and 
Scx/Sema3D, and the observation, that some, but not all, proepicardial cells are able to 
differentiate into cardiac myocytes in vitro.75,76 The latter might be substantiated in the 
common origin of at least some of the proepicardium-cells and the cardiomyocyte lineages, 
indicated by lineage tracings for early cardiogenic transcription factors.29,77 Nevertheless, a 
contribution of epicardial cells to the cardiomyocyte lineage cannot be substantiated by the 
current state of scientific knowledge. The proposed endothelial fate of epicardial cells, based 
on the Scx/Sema3D lineage tracings, might be questioned, because a potential expression of 
these markers in the sinus venosus endothelium - which gives rise to the coronary 
endothelium27 - has not been addressed so far. These data suggest that some cells within 
the proepicardium are not fully dedicated to an epicardial cell fate, however cells of the 
epicardium only give rise to the canonical epicardial lineage. 
Complex signaling events govern the mobilization and differentiation of EPDCs. However, 
the reevaluation of the epicardium-specific loss of Ctnnb1, Fgfr1/2, Shh and the Hh receptor 
Smoothened did not reveal any contribution to these processes. Recombination in non-
epicardium-derived cells may account for the detected phenotypes in previous 
studies.34,48,53,58 Especially, the loss of Hh and canonical Wnt signaling in coronary 
endothelial cells might be causative for the observed coronary vasculature defects that in 
turn might influence smooth muscle cell differentiation. In addition, conditional approaches 
using Wt1cre imply already a heterozygous loss of Wt1, which possibly interferes with the 
mobilization of EPDCs. Thus the impaired EMT observed in Wt1cre mediated loss of Ctnnb1 
and Fgfr1/2 can be questioned in this context. The requirement of the Notch signaling 
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pathway for the differentiation of perivascular smooth muscle cells was shown and the 
necessity of Pdgfrα signaling for EMT and fibroblast differentiation was confirmed in this 
study. This results in a simplified model of molecular signaling pathways in the mobilization 
and differentiation of epicardial cells in embryonic development. 
Interestingly, Tbx18 and Wt1 – normally present only in the embryonic epicardium – are re-
expressed in the murine heart after myocardial infarction. These studies on the one hand 
indicate that the canonical epicardial lineage is recapitulated in these conditions, but leave 
open that EPDCs might - at low frequencies - differentiate into mature cardiomyocytes in the 
presence of injury on the other.78,79 In these experiments the fate of epicardial cells was 
followed with Wt1cre lines. However, in the infarcted rat heart Wt1 is re-expressed additionally 
in coronary endothelial and smooth muscle cells in the infarct border zone.80 Considering the 
fact that Wt1 is upregulated by ischemic cues,81 its expression in the border zone may reflect 
the ischemic conditions rather than being an indication of epicardial activation and EMT. 
Wound healing after myocardial infarction might be dependent on cells of the canonical 
epicardial lineage, which secrete proangiogenic growth factors.82 In independent studies 
Notch and Wnt signaling were found to be upregulated in the regions of injury and the loss of 
Wnt1 impaired wound healing.83,84 Given the potential of Wnt signaling in proliferation control 
and the requirement of Notch signaling in differentiation of coronary smooth muscle cells, the 
impact of these signaling pathways on EMT and secretion of growth factors in the adult 
epicardium ought to be analyzed in the future.  
 
Although our findings indicate that epicardial cells are not a natural source of cardiomyocytes 
in development, the possibility remains that experimental manipulation of these cells may be 
used for regenerative therapies. For this purpose inducible epicardium-specific cre-lines like 
the Upk3bcreERT2 line are needed. 
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